Movatterモバイル変換


[0]ホーム

URL:


USRE50219E1 - Method and apparatus for controlling a ventilator - Google Patents

Method and apparatus for controlling a ventilator
Download PDF

Info

Publication number
USRE50219E1
USRE50219E1US17/727,065US202217727065AUSRE50219EUS RE50219 E1USRE50219 E1US RE50219E1US 202217727065 AUS202217727065 AUS 202217727065AUS RE50219 EUSRE50219 EUS RE50219E
Authority
US
United States
Prior art keywords
patient
peep
measured
value
data indicative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US17/727,065
Inventor
Fleur T Tehrani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=34594521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE50219(E1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by IndividualfiledCriticalIndividual
Priority to US17/727,065priorityCriticalpatent/USRE50219E1/en
Application grantedgrantedCritical
Publication of USRE50219E1publicationCriticalpatent/USRE50219E1/en
Activelegal-statusCriticalCurrent
Adjusted expirationlegal-statusCritical

Links

Images

Classifications

Definitions

Landscapes

Abstract

Method and apparatus for controlling a ventilator are described. The invention can be used to control mechanical ventilators as well as respiratory assist devices such as CPAP machines. The apparatus receives input data indicative of patient's oxygen level. A controller determines PEEP, or CPAP, and FIO2, on the basis of data indicative of the patient's oxygen level. In an alternative embodiment, the apparatus further receives input data indicative of patient's carbon dioxide levels, respiratory elastance and airway resistance, and barometric pressure. The controller further utilizes the said input data to determine the optimal values of tidal volume and breathing frequency for a next breath of the patient, and uses the respiratory elastance and airway resistance data to determine any necessary adjustments in the I:E ratio. The controller also applies safety rules, detects and corrects artifacts, and generates warning signals when needed.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This application is a reissue patent application of U.S. nonprovisional patent application Ser. No. 10/935,446, filed Sep. 7, 2004, now issued U.S. Pat. No. 7,802,571, which claims the benefit of U.S. provisional patent application No. 60/481,693, filed Nov. 21, 2003, the entire contents of which are incorporated herein by reference. This application is related to U.S. Pat. No. 4,986,268 entitled “Method and Apparatus for Controlling an Artificial Respirator,” the disclosure of which is incorporated by reference.
BACKGROUND OF INVENTION
1. Field of the Invention
The present invention relates to a method and apparatus for controlling a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device. In particular, the present invention relates to a method and apparatus for controlling a ventilator based on the measured levels of oxygen of the patient on the ventilator, as well as other physical conditions of the patient.
2. Background of the Invention
Mechanical ventilators and other respiratory assist devices are extensively used to treat and manage all patient populations. In the past few decades, there have been significant changes in the features offered by the ventilators and they have become increasingly responsive to individual patient needs. However, despite much advancement in these devices, most ventilators used today are still mainly open-loop controlled devices and their added features have to some extent contributed to their complexity. The clinicians are required to make many important selections among the wide range of options available in advanced mechanical ventilators. Optimal adjustment of these machines oftentimes requires in depth knowledge about the ventilator along-with thorough review of the patient's status and his/her underlying illness. These adjustments are particularly cumbersome and frequent in more fragile and less medically stable patients.
There have been many attempts in the past to automatically control some of the main outputs of mechanical ventilators. See Y. Mitamura et al., “A dual control system for assisting respiration,” Medical and Biological Engineering, vol. 13, no. 6, pages 846-854, 1975, Yu et al., “Improvement in arterial oxygen control using multiple model adaptive control procedures,” IEEE Transactions on Biomedical Engineering, BME-34(8), pages 567-574, 1987, and U.S. Pat. No. 4,986,268 to F. T. Tehrani, issued Jan. 22, 1991, entitled “Method and apparatus for controlling an artificial respirator.”
Also, see U.S. Pat. No. 5,103,814 to T. Maher, issued Apr. 14, 1992, entitled “Self-compensating patient respirator,” Morozoff P. E., and Evans R. W., “Closed-loop control of SaO2in the neonate,” Biomedical Instrumentation and Technology, vol. 26, pages 117-123, 1992, U.S. Pat. No. 5,365,922 to D. B. Raemer issued Nov. 22, 1994 entitled “Closed-loop non-invasive oxygen saturation control system,” Tehrani et al. “Closed-loop control of the inspired fraction of oxygen in mechanical ventilation,” Journal of Clinical Monitoring and Computing, vol. 17, No. 6, pages 367-376, 2002, and U.S. Pat. No. 6,671,529 to N. R. Claure et al., issued Dec. 30, 2003, entitled “System and method for closed-loop controlled inspired oxygen concentration.”
Some of the prior art on this subject is focused on controlling the patient's oxygenation, and some is intended to automatically control the breathing frequency and tidal volume. The systems intended for controlling only the oxygen level of the patient on the ventilator, either do not provide the automation of all factors that affect oxygenation and/or they do not provide a reliable and sufficiently robust response against oxygen disturbances.
In addition to advancement in mechanical ventilators, there have been many attempts in recent years to prevent the collapse of the airways and apnea in spontaneously breathing patients specially during sleep, by using less elaborate machines than mechanical ventilators, generally known as CPAP machines (CPAP stands for Continuous Positive Airway Pressure). In these machines, either a constant pressure is applied to the patient's airways throughout respiration (i.e. CPAP), or a combination of CPAP and pressure support in inspiration is used to ventilate the patient (e.g. bilevel CPAP machines). See U.S. Pat. No. 4,773,411 to J. B. Downs issued Sep. 27, 1988, entitled “Method and apparatus for ventilatory therapy,” International Patent Publication No. WO 99/61088 to Resmed Limited, issued Dec. 2, 1999, entitled “Ventilatory assistance for treatment of cardiac failure and Cheyne-Stokes breathing,” U.S. Pat. No. 6,539,940 to R. J. Zdrojkowski et al., issued Apr. 1, 2003, entitled “Breathing gas delivery method and apparatus,” and U.S. Pat. No. 6,752,151 to P. D. Hill, issued Jun. 22, 2004, entitled “Method and apparatus for providing variable positive airway pressure.”
In one embodiment, the present invention describes a method and apparatus that can reliably and robustly control PEEP (or CPAP), and FIO2. These are novel features which significantly improve the oxygenation of patients during ventilatory therapy provided by mechanical ventilators as well as respiratory devices such as CPAP machines.
Furthermore, in a more elaborate embodiment of the invention, in addition to PEEP (or CPAP) and FIO2, the I:E ratio of the patient can be automatically adjusted and by further inclusion of the features of U.S. Pat. No. 4,986,268, the breathing frequency, and tidal volume can be automatically controlled in mechanical ventilation. Application of these features results in a significantly more effective and optimal treatment to the patient based on his/her conditions and requirements, in total or assist ventilatory therapy.
SUMMARY OF INVENTION
A method and apparatus for controlling a ventilator includes first means receiving at least input data indicative of the patient's measured oxygen levels, and in a more elaborate embodiment of the invention, the first means also receives respiratory mechanics and/or pressure-volume data, as well as data indicative of measured carbon dioxide levels of the patient. The first means which preferably comprises a programmable microprocessor, is controlled by a software algorithm to operate on the input data, and to provide digital output data to control the ventilator and the gas mixer of the ventilator. The software algorithm is divided into two control programs. One control program which can either be used by itself or along with the other program, is designed to automatically adjust FIO2and PEEP (or CPAP), based on at least the measured oxygen levels of the patient. The control program also operates on data from a pressure volume (PV) monitor/analyzer to set the initial PEEP value in certain groups of respiratory patients. The processing means detects hazardous conditions based on the input data and/or artifacts, replaces and/or corrects the measurement artifacts, and instructs generation of appropriate warning signals. The other control program, most of which is described in U.S. Pat. No. 4,986,268, is designed to control the frequency and ventilation for a next breath of the patient on the ventilator based on at least data indicative of measured CO2and O2levels of the patient, barometric pressure (as a reference pressure), and respiratory elastance and airway resistance (respiratory mechanics) data; and to make necessary adjustments in the I:E ratio based on the patient's respiratory mechanics data. The output data from the 1stmeans indicative of PEEP (or CPAP), FIO2, the adjustment in the I:E ratio, breathing frequency, and ventilation, and status of alarms are transmitted to a Signal Generator which is equipped with converters and/or other electronic components to generate the control and appropriate warning signals. The control signals for the breathing frequency, ventilation, PEEP (or CPAP), and the adjustment in the I:E ratio are supplied to the ventilator. The control signal for FIO2is supplied to a mixer regulator unit which adjusts the concentration of oxygen added to the inhalation gas in the gas mixer of the ventilator. Based on the instructions from the 1stmeans, the alarm circuit generates appropriate warning signals when needed.
BRIEF DESCRIPTION OF DRAWINGS
FIGS.1-4 illustrate a preferred embodiment of the present invention. However, it is understood that this invention is not limited to the precise arrangements shown in the figures and can be embodied in other arrangements without deviating from the scope of the invention.
FIG.1 is a block diagram of a mechanical ventilator and the control apparatus according to an alternative embodiment of the invention.
FIGS.2a-2c show the flow chart of a software algorithm that also incorporates the control technique described in U.S. Pat. No. 4,986,268, to automatically control breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient on the ventilator, according to a preferred method of the present invention.
FIGS.3a-3i show the flow chart of a software algorithm to automatically control PEEP (or CPAP) and FIO2according to a preferred method of the present invention.
FIG.4 shows a preferred detailed schematic diagram of a Signal Generator and an Alarm Circuit, for use in a preferred practice of the present invention.
DETAILED DESCRIPTION
Definitions
In the specification and claims:
    • 1—The term “ventilator” refers to a device which is used to provide total or assist ventilatory treatment to patients, and includes mechanical ventilators (i.e. artificial respirators) or CPAP (Continuous Positive Airway Pressure) machines.
    • 2—The term “PEEP” represents “Positive End-Expiratory Pressure” and is interchangeable with the term “CPAP,” which represents “Continuous Positive Airway Pressure,” for example, when assist ventilation is provided to spontaneously breathing subjects.
    • 3—The term “FIO2” represents “concentration of oxygen in a patient's inspiratory gas” which is the same as “fraction of inspired oxygen.”
    • 4—The term I:E represents the “ratio of inspiration time to expiration time.”
DESCRIPTION OF PREFERRED EMBODIMENTS
FIG.1 shows a block diagram according to an alternative practice of the present invention. Thedigital processor10 includes a programmable controller coupled to receive the outputs of 8 bit A/D converters12,14 and16 as shown. The A/D converters18 and20 are each a single 8 bit A/D converter. The A/D converter unit22 is an A/D board containing three 8 bit A/D converters. Theinputs24,26, and28 of the A/Ds are from an oxygen sensor, preferably a pulse oximeter,30, a CO2sensor, such as a transcutaneous monitor or preferably a capnograph,32, and a lung mechanics calculator and PV monitor,34. Theoutputs24, and26 are each a single analog signal while theoutput28 represents 3 analog signals; 1—representing respiratory elastance, 2—representing respiratory airway resistance (air viscosity factor in the lungs), and 3—representing the lower inflection point on the inspiratory or expiratory PV curve of the patient, or alternatively, the measured intrinsic PEEP (PEEPi) of the patient on the ventilator. The inputs to the oxygen sensor and the carbon dioxide sensor are respectively shown at40 and42 coming from the patient. Theinput40 is preferably the arterial hemoglobin oxygen saturation data and the input to the CO2sensor shown at42 is preferably the exhaled gas from the patient from which the end-tidal CO2concentration or the end-tidal partial pressure of CO2is determined by the sensor. The lung mechanics calculator and PV monitor,34, receives data from the mechanical ventilator shown at56, or from the patient through the ventilator circuit, on the line illustrated at36 and communicates back to the ventilator as shown at38. The digital processor's outputs shown at44 are applied to a Signal Generator Circuit, illustrated at46. The Signal Generator Circuit sends alarm instruction signals52 to thealarm circuit54.
Themechanical ventilator56 receives the control signals48 from theSignal Generator Circuit46. These consist of signals to control PEEP, breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient. AMixer Regulator circuit58, receives control signals to adjust FIO2,50, from theSignal Generator Circuit46. Anoxygen air mixer62 receives the adjustedoutput signal60 from theMixer Regulator58. The concentration of oxygen in the mixer is thereby adjusted by mixing the determined concentration ofoxygen66 coming from theoxygen supply70 and that ofair64 coming from theair compressor68. The enriched oxygenatedair72 from the mixer is provided to theventilator56 which delivers it to the patient at74.
Referring toFIG.2a-2c, there is illustrated a flow chart of the algorithm to control the breathing frequency, ventilation, and the adjustment in the I:E ratio in an alternative embodiment of the invention. As seen at the start of the flow chart, the initial values of breathing frequency and tidal volume are transmitted to the output ports instep100. Then the main loop at A is started and in the next step at102, based on data indicative of CO2and O2levels of the patient which are preferably provided by a capnograph and a pulse oximeter respectively, the arterial partial pressures of CO2and O2are calculated by using the following equations:
PaCO2=PetCO2+K1
PaO2=-ln[1-(SpO2)0.5]0.046+CP
Where PaCO2and PaO2are arterial partial pressures of CO2and O2respectively, PetCO2is the end-tidal partial pressure of CO2measured by the CO2sensor, and K1is the difference between the arterial partial pressure of CO2and the end-tidal partial pressure of CO2. K1can be measured in advance and depending on the patient's conditions, it can be adjusted to set the desired PaCO2of the patient. SpO2is the arterial hemoglobin oxygen saturation of the patient measured by a pulse oximeter and CP is an added correction factor which is used to correct and shift PaO2based on the patient's measured blood pH level. If the patient's blood pH level is in the 7.45-7.55 range, CP is set to zero. Otherwise, CP needs to be adjusted by +3.5 mm Hg per every −0.1 deviation in pH from the above range. After the calculation of PaCO2and PaO2, their values are compared to defined minimum acceptable levels to determine whether there has been any measurement artifact instep104. If any artifact is detected, the calculated value is discarded and the previous calculated value is resumed. In the next step at106, if PaCO2and/or PaO2are not within certain defined ranges, alarms are transmitted to the output ports. In the step that follows at108, if the calculated PaCO2and PaO2values are both lower than their minimum threshold limits (which are different from the minimum acceptable values used in step104), the possibility of pulmonary embolism is assumed, predefined levels of ventilation and breathing frequency are provided, and an alarm is generated insteps110 and112, and the program returns to A. However, if the calculated PaCO2and PaO2values are not found to be simultaneously lower than their minimum threshold levels in108, then the effect of CO2on the required ventilation is calculated in step114:
VC=C1.PaCO2−C2
Where VCis the ratio of alveolar ventilation as the net effect of CO2to the resting value of ventilation, C1is the sensitivity factor of the controller to CO2(e.g., C1=0.405) and C2is a constant (e.g., C2=14.88).
Next, instep116, the PaO2value is compared to a high threshold limit of 104 mm Hg. If PaO2is greater than or equal to this threshold value, the effect of oxygen on ventilation is set to zero in118, and the next step at122 is followed. Otherwise, if PaO2is found to be less than the threshold value instep116, then control is passed to step120 in which the effect of oxygen on the required ventilation is calculated by using the following equation:
VO=(4.72×10−9)(104−PaO2)4.9
Where VOis the ratio of alveolar ventilation as the net effect of oxygen to the resting value of ventilation. It is recognized that the above equations are based on the use of a capnograph and a pulse oximeter to measure the carbon dioxide and oxygen levels of the patient respectively. If other measurement techniques are utilized to provide data indicative of said levels, then other alternative equations may be used to determine the required ventilation for the patient, without deviating from the scope and the essential attributes of the invention.
In the next step at122, the effect of increase in the metabolic rate ratio, MRR, (i.e. rate of metabolism/basal rate of metabolism), on ventilation is calculated by using the following equation:
VM=0.988(MRR−1)
Where VMis the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation, and MRR is an input to the algorithm. In the next step at124, total alveolar ventilation for the next breath is calculated:
VA=(VAat rest)(VC+VO+VM)
Where VAis alveolar ventilation in liters/minute and VAat rest is the alveolar ventilation at rest which is input and stored in the software. In the next step at126, the physiological dead space of the patient, and the total dead space including that of the equipment are calculated, if not provided in advance, as follows:
VD=(0.1698VA/60)+0.1587
VDt=VD+VED
In these equations, VDis the patient's dead space in liters, VEDis the equipment dead space due to the tubes and connections, and VDtis the total dead space. It should be noted that the constant factors in these equations are based on measured experimental values for adults and can therefore be different for individual patients. Also, for other patient populations, they need to be adjusted. For example the constant factor of 0.1587 should change to a much smaller value for infants (e.g., 2.28×10−3). In the next step at128, data indicative of barometric pressure and the patient's airway resistance (or the air viscosity factor in the lungs) and respiratory elastance are read from the input ports. The barometric pressure data which is affected mostly by the altitude, is used as a reference pressure (for the purpose of calibration) in the invention.
In the next step at130, the optimal frequency for the next breath is computed. This calculation is based on minimization of the respiratory work rate and is done in order to stimulate natural breathing, provide a more comfortable breathing pattern to the patient, and thereby, expedite the weaning process in assisted ventilation. The following equation, which is a modified version of an equation derived in 1950 by Otis et al. to describe the control of breathing frequency in mammals, is used to calculate the optimal breathing frequency in the invention:
f=-KVD+(KVD)2+4KKΠ2VARVD2KΠ2VD
where f is the optimum breathing frequency in breaths/second, VARis the alveolar ventilation in liters/second and is equal to VA/60, K′ is the respiratory elastance (reciprocal of respiratory compliance) in cm H2O/liter and K″ is the airway resistance in cm H2O/liter/second. Next instep132, the required minute ventilation and tidal volume are calculated:
VE=VA+60fVDt
VT=VA/60f+VDt
Where VErepresents total minute ventilation in liters/minute and VTis tidal volume in liters. In the next step at134, additional safety rules are applied. If breathing frequency, f, tidal volume, VT, or minute ventilation are not within prescribed safe ranges, their values are limited and adjusted.
In thenext step136 which follows, the breathing frequency is compared with an upper limit value Fmax. This upper limit frequency is defined as:
Fmax=⅕τ
Where τ is the respiratory time constant and is equal to K″/K′. If instep136, the breathing frequency is found to be higher than Fmax, then in the next step at138, its value is reduced to Fmax(in which case VTis also adjusted according to procedures insteps132 and134), and step140 is followed. Otherwise, if the computed breathing frequency is less than or equal to Fmax, it does not need further adjustment and the program is transferred to step140. Instep140, the expiration time, TE, is compared to 2.5 times τ. If it is found to be less than 2.5 τ, then step142 is followed and the I:E ratio (the ratio of the inspiratory time to the expiratory time) is adjusted, so that TEbecomes at least equal to 2.5 τ. Otherwise, if TEis found to be greater than or equal to 2.5 τ instep140, it does not need to be adjusted (i.e. the adjustment value is zero) and the program is transferred to step144. The reason for the adjustments in the breathing frequency and TEinsteps138 and142 mentioned above, is to provide sufficient time for exhalation based on the patient's respiratory time constant and to avoid build up of intrinsic positive end-expiratory pressure (PEEPi).
Instep144 that follows, the calculated values for ventilation, breathing frequency, and the adjustment in the I:E ratio for the next breath are provided to the output ports. At this point, if the ventilator is in the pressure control/assist mode, the inspiratory pressure is calculated by using the following equation:
Pm=K′VT+PEEP
where Pmis the inspiratory pressure in cm H2O. Thereafter, the control data indicative of Pmis also provided to an output port and the routine is held for the duration of the next breathing cycle. After the delay is passed, the program returns to the beginning of the loop at A.
It should be noted that the major portion of the procedure depicted inFIG.2 to calculate the optimal breathing frequency and tidal volume of the breaths of a patient and controlling them automatically, has been described in U.S. Pat. No. 4,986,268. In the present invention, the necessary adjustments in the I:E ratio are controlled automatically as described above, and the levels of FIO2and PEEP are automatically controlled by another algorithm which is described next.
Referring toFIGS.3a-3i, there is illustrated a flow chart of a control algorithm which is operated upon by the digital processor. This algorithm is either run by itself, or in an alternative embodiment of the invention, it is run in parallel to the algorithm ofFIGS.2a-2c described above. The purpose of this algorithm is to automatically control the levels of FIO2and PEEP provided to the patient on the ventilator and thereby improve the patient's oxygenation. The method depicted inFIGS.3a-3i can be used for patients on mechanical ventilation or those on respiratory assist devices receiving CPAP treatment. Depending on the type of the ventilatory treatment, the term PEEP in the flow chart is meant to be interchangeable with CPAP.
As is seen, at the start of the flow chart, the desired set point for arterial partial pressure of oxygen of the patient is defined instep200. This is done on the basis of the patient's conditions and his/her underlying illness. Then in the next step at202, the initial value of FIO2is set and transmitted to the output port.
Instep204 that follows next, the initial value of PEEP is set and transmitted to an output port. The initial value of PEEP can be set by using different options. For certain patient groups such as COPD patients, the initial PEEP can be chosen to be 80% to 85% of the intrinsic PEEP (PEEPi) which needs to be measured in advance. For some other patient groups such as ARDS patients, the initial PEEP setting can be chosen to be 3-4 cm H2O above the lower inflection pressure point of the inspiratory (or the expiratory) pressure volume curve of the patient. This value can either be calculated by the lung mechanics calculator and PV monitor unit and provided automatically to the digital processor via an input port, or the calculated value of the pressure can be provided manually by the clinician either through one of the input ports or via software. The third option is that the clinician arbitrarily decides an initial setting for PEEP and provides it to the digital processor, preferably via software. After setting the initial PEEP value in204, the next step in206 is followed. At this point, a time parameter (e.g., TP) for PEEP adjustment is defined and initially set to zero. The purpose of defining this parameter is to guarantee that PEEP adjustments are done only after a certain time has elapsed since the latest adjustment, thereby giving enough time to an adjustment in PEEP to make an impact on the patient's oxygenation.
Instep208 which follows next, another parameter, AP, for PEEP adjustment is defined. If this parameter is set to zero, then PEEP is controlled manually and only FIO2is automatically adjusted. If AP is set to one, then both FIO2and PEEP are automatically controlled.
In thenext step210, the threshold values for arterial hemoglobin oxygen saturation, SpO2, (or alternatively for arterial partial pressure of oxygen) are defined. In a preferred practice of the invention, four threshold values are defined for SpO2and they are set at 90%, 93%, 95%, and 97% respectively. However, the threshold values may differ for different patients. They should be defined based on the patient's conditions and the desired levels of oxygenation.
Next, program control passes to step212 in which a loop indicator (e.g., LI) is defined and is set to 1.5, and the main loop starts at A′.
In the next step in214, the patient's SpO2data is read from one of the input ports, and instep216, the arterial partial pressure of oxygen is calculated from the SpO2data as:
PaO2=-ln[1-(SpO2)0.5]0.046+CP
Where PaO2is the arterial partial pressure of oxygen, and CP is an added correction factor which is used to shift PaO2based on the patient's measured blood pH level. If the patient's blood pH is within 7.45-7.55, then CP is set to zero. Otherwise, for every +0.1 deviation in pH from this range, CP is adjusted by −3.5 mm Hg as was also mentioned in the description ofFIG.2 earlier.
Instep218 that follows next, the calculated partial pressure of oxygen, PaO2, is compared with a minimum acceptable value. This is done to detect artifacts in the measurement of SpO2. If the calculated PaO2is found to be less than the minimum acceptable value, then control passes to step220 in which an artifact is assumed and an alarm is generated. Then step222 is performed in which the SpO2data is discarded and the previous value Of PaO2in the memory is resumed andstep224 is followed. However, if in218, the calculated PaO2is found to be greater than or equal to the minimum acceptable value, its value is accepted and control passes to step224.
Instep224, SpO2is compared to a minimum safe value, which is the first threshold value defined previously in step210 (e.g., 90%). If SpO2is less than or equal to the minimum safe value, loop B is started in226 and the loop indicator, LI, is set to 2.5. Then instep228, FIO2is increased stepwise (i.e. in a step-like arrangement) to a high value, F1, (e.g., 60%), and an alarm is generated in230. Control then passes to loop F at which the procedure of PEEP adjustment begins as will be described later. However, if SpO2is found to be higher than the minimum safe value instep224, control passes to232 where SpO2is compared to a second threshold value (e.g., 93%). If SpO2is less than the second threshold value, then steps234 and236 are followed in which the loop indicator, LI, is examined and compared to 2. If LI is less than 2, control passes to another loop E which will be described later. If LI is greater than or equal to 2, the next step in238 is performed in which LI is compared to 3. If LI is less than 3, control passes to loop B (where FIO2was set high at F1, e.g., 60%), otherwise, the program transfers to step240. In this step, LI is compared to 4. If it is less than 4, control passes to loop C; otherwise, the program transfers to loop D (loops C and D will be described later).
Back to step232, if SpO2is found to be higher than or equal to the 2ndthreshold value (e.g., 93%), then steps242 and244 are followed in which LI is compared to 2. If it is less than 2, control passes to loop E. Otherwise, in the next step at246, LI is compared to 3. If less than 3, loop C is defined and started at248, and LI is set to 3.5. Then instep250, FIO2is set stepwise at a moderately high value, F2 (e.g., 45%), and control transfers to loop F in which the procedure of PEEP adjustment is followed. However, if instep246, LI is found to be greater than or equal to 3, control passes to step252 in which LI is compared to 4. If LI is less than 4, then SpO2is compared to a third threshold value (e.g., 95%) instep254. If SpO2is less than the third threshold value, control passes to loop C in which FIO2was set at a moderately high level, F2 (e.g., 45%). Otherwise, if SpO2is found to be higher than or equal to the third threshold value in254, then the next step in256 is followed in which loop D is defined and started and LI is set to 4.5. Next instep258, FIO2is set stepwise at a slightly high level, F3 (e.g., 30%), and control passes to loop F.
Back to step252, if LI is found to be greater than or equal to 4, then SpO2is compared to a 4ththreshold value (e.g., 97%) instep260. If SpO2is less than the 4ththreshold value, control passes to loop D in which FIO2was set at a slightly high value, F3 (e.g., 30%). Otherwise, if SpO2is higher than or equal to the 4ththreshold value in260, then loop E is started in262 and LI is set to 1.5. In loop E, a proportional, integral, derivative (PID) control procedure is performed to adjust FIO2(PID control is a control technique comprising proportional, integral, and derivative terms). In the next step at264, using the PaO2set point defined instep200, the proportional, differential, and integral components of error are calculated as follows:
Y1(k)=PaO2(set-point)−PaO2
Y2(k)=[Y1(k)−Y1(k−1)]/T
Y3(k)=Y3(k−1)+TY1(k)
In the above equations, Y1(k), Y2(k), and Y3(k) represent the proportional, differential, and integral components of error in PaO2respectively, and T is a sampling interval.
Instep266 that follows, the required FIO2is calculated by using the following equations:
E(k)=αY1(k)+βY3(k)+γY2(k)
G(k)=E(k)+0.21
Where E(k) is an error function, α, β, and γ are the PID coefficients, and G(k) is the required FIO2. In a preferred practice of the invention, T is set to 0.75 seconds, and α, β, and γ are set to 6.45×10−5, 3.22×10−5, and 7.29×10−6respectively. These parameters were tuned to minimize steady-state oscillations and to keep the overshoot/undershoot in the FIO2response of the PID controller below 25% of the total change. It is also recognized that other error correction schemes can be used to determine FIO2. As long as those schemes reduce the error in the oxygen level of the patient in a similar way as described above, they will be within the scope of the present invention.
In the next step in268, the calculated value of FIO2is compared with a minimum of 0.21 (i.e. 21%). If the FIO2value is less than 21%, instep270 which follows, it is set to a minimum of 21% and control passes to loop F. However, if in268, FIO2is found to be greater than or equal to 21%, control passes to step272 in which FIO2is compared to a maximum allowed value (e.g., 80%). If FIO2is less than or equal to the maximum allowed value, the next step in274 is followed where the calculated value of FIO2is sent to the output port and control passes to step276. In this step FIO2is compared to 60%. If it is less than 60%, control passes to loop F. Otherwise, an alarm is generated in278 and then control transfers to loop F.
Back to step272, if the calculated value of FIO2is found to be higher than the maximum allowed value, it is reduced to the maximum value instep280, an alarm is generated, and then control transfers to loop F.
Up to the beginning of loop F atstep282, the focus of control is on automatic control of FIO2. As shown, two different mechanisms are incorporated in the control process of FIO2in a preferred practice of the invention. One, a rapid stepwise control scheme which responds instantly to fast declines in SpO2, and the other, a more finely controlled PID algorithm that provides fine control of FIO2in the absence of sharp and hazardous declines in SpO2. The stepwise controller in a preferred practice of the invention has three loops, each with its defined minimum and maximum SpO2threshold levels. These three loops were shown respectively at B, C, and D, and the PID control loop was shown at E in the flow chart ofFIG.3. The controller switches from the PID control to the rapid stepwise algorithm only if rapid declines in SpO2are detected. Once in the stepwise mode, the controller continuously checks SpO2, and if it rises, the controller reduces FIO2to minimize the exposure of the patient to high and toxic levels of FIO2. The controller is designed to correct hypoxemia within seconds and to avoid hyperoxemia. As shown, the controller detects artifacts in the measurement of SpO2, discards the artifacts, and generates alarms when appropriate. The algorithm also enables clinicians to define the desired oxygenation levels for different patients. This is done by defining an appropriate PaO2set point, by setting the threshold values for SpO2, and by adjusting the correction parameter, CP, in accordance with the measured pH levels in the patient's blood as described above.
After the determination of the required FIO2, the procedure of adjusting the PEEP value is started at F instep282. In this step, the ratio of PEEP/FIO2is calculated. Then in284, the control parameter AP, which was defined instep208, is examined. If it is less than 1, it means that PEEP is not adjusted automatically and it is instead adjusted manually by the operator. In this case, the controller merely watches the PEEP/FIO2ratio and generates warning signals, if the ratio is either too low or too high. Instep286, the ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum value, an alarm is generated in288 and control passes to I (which will be described later). However, if the PEEP/FIO2ratio is found to be equal to or greater than the minimum value instep286, then the next step in290 is performed where the ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is less than or equal to the maximum value, control passes to I. Otherwise, an alarm is generated instep292 and then control is transferred to I.
Back to step284, if AP is not less than 1, it means that PEEP should be calculated and automatically adjusted. Therefore, the automatic PEEP adjustment control loop is started next at G atstep294. In thestep296 that follows, the PEEP/FIO2ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum, the procedure at H is started and it is examined how long ago the last adjustment in PEEP was made. Instep300 that follows, the time parameter, TP, is compared to a defined fixed interval, T1, for example 240 seconds. If TP is less than 240 seconds, it means that the last PEEP adjustment was made less than 4 minutes ago. Then the procedure at J is started. Control passes to step302 in which no change is made in PEEP and the time parameter, TP, is increased by a fixed amount (e.g., 0.75 seconds):
TP(new)=TP(old)+0.75
Thereafter, control passes to I. However, if instep300, it is found that TP is equal to or greater than 240 seconds, it means that the last adjustment in PEEP was made at least 4 minutes ago or longer. Therefore, control passes to step304. In this step, TP is set back to zero. Then in306 that follows, PEEP is increased by a fixed amount (e.g., 2 cm H2O):
PEEP(new)=PEEP(old)+2 cm H2O
Thereafter, control passes to I.
Back to step296, if the PEEP/FIO2ratio is not found to be less than the minimum allowed value, control transfers to step308. In this step the PEEP/FIO2ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is not less than the maximum value,step310 is next performed. At this point, the PEEP/FIO2ratio is compared to a slightly higher value than the maximum, RG, (e.g., 0.24). If it is not greater than this value, control passes to J. Otherwise;step312 is performed in which the time parameter, TP, is compared to the fixed interval of 240 seconds. If TP is less than 240 seconds, control passes to J. Otherwise; TP is set back to zero instep314, and PEEP is reduced by a fixed amount (e.g., 2 cm H2O) in step316:
PEEP(new)=PEEP(old)−2 cm H2O
Thereafter, control passes to I. Instep318 at I, the routine is held for a fixed interval (e.g., 0.75 seconds) and then control returns to the beginning of the main loop at A′.
Back to step308, if the PEEP/FIO2ratio is found to be less than the maximum allowed limit (e.g., 0.22), thestep320 is next followed. In this step SpO2is compared to a predefined minimum allowed value (e.g., 92%). If it is higher than or at least equal to the predefined minimum value, the PEEP level is not changed and control passes to J. However, if in320, SpO2is found to be less than the predefined minimum value, then control passes to H, where it is determined whether at least 4 minutes have passed since the last PEEP adjustment, and if so, PEEP is increased by a fixed amount (e.g., 2 cm H2—O) as was shown earlier.
In performing the automatic PEEP adjustments, the PEEP/FIO2is kept within a clinically acceptable range. As shown above, if the PEEP/FIO2is too low, PEEP is increased by a fixed increment (e.g., 2 cm H2O). Also, if the PEEP/FIO2ratio is within the acceptable range and SpO2is low, then PEEP is increased by a fixed increment (e.g., 2 cm H2O) to improve patient's oxygenation. On the other hand, if the PEEP/FIO2ratio increases beyond a maximum defined value, the program reduces PEEP in fixed amounts (e.g., 2 cm H2O). In any case, the interval between two successive PEEP adjustments is at least equal to a fixed period (e.g., 240 seconds), to allow for the changes in PEEP to have an observable and measurable impact on the patient's oxygenation.
It should be noted that the above examples for the incremental step size for PEEP adjustment (e.g. 2 cm H2O) and the minimum and maximum values for the ratio of PEEP/FIO2, are indicated for patients receiving ventilatory treatment in a more acute clinical setting such as the intensive care or a constant care unit of a hospital. Smaller incremental adjustments (e.g. 1 cm H2O) and more conservative ranges for the ratio of PEEP (or CPAP)/FIO2may be adopted if the invention is used to improve the breathing and oxygenation of more stable, spontaneously breathing patients.
FIG.4 illustrates in detail, a preferred circuit diagram of the Signal Generator Circuit,46, and thealarm circuit54. The preferred component types and values are shown in the chart below:
ComponentType/Value
IC1DAC0802LCN
IC2LM741CN
IC3SN7400N
C10.1μF
C20.03μF
D11N4148
R15.1
R250kΩ pot
R
310kΩ pot
R42.7
R5330Ω
There has been described a method and apparatus for controlling a ventilator. The invention utilizes data indicative of measured oxygen levels of the patient to automatically control FIO2, and PEEP (or CPAP). In an alternative embodiment, the invention further uses the respiratory mechanics data (i.e. respiratory elastance and airway resistance) to automatically make the necessary adjustments in the I:E ratio of the patient on the ventilator. It further incorporates the features of U.S. Pat. No. 4,986,268 and uses data indicative of measured levels of oxygen and the respiratory mechanics data of the patient, along with data indicative of barometric pressure (as a reference calibrating pressure), and data indicative of measured carbon dioxide level of the patient to automatically control the breathing frequency and tidal volume of breaths of the patient on the ventilator. The invention also detects and corrects artifacts in the measured oxygen and carbon dioxide data and applies safety rules. In its different embodiments, the invention can improve total and/or assist ventilatory treatments provided to different patient groups.
The present invention may be embodied in other specific forms without departing from the scope and the essential attributes thereof. Therefore, reference should be made to the appended claims rather than to the foregoing specification, with regard to the scope of the invention.

Claims (87)

What is claimed is:
1. An apparatus for automatically controlling a ventilator comprising:
first means for processing data indicative of at least a measured oxygen level of a patient, and for providing output data indicative of:
required concentration of oxygen in inspiratory gas of the patient (FIO2) and positive end-expiratory pressure (PEEP) for a next breath of the patient;
wherein FIO2is determined to reduce the difference between the measured oxygen level of the patient and a desired value;
wherein PEEP is determined to keep a ratio of PEEP/FIO2within a prescribed range and, while keeping the ratio within the prescribed range, to keep the measured oxygen level of the patient above a predefined value; and
second means, operatively coupled to the first means, for providing control signals, based on the output data provided by the first means, to the ventilator;
wherein the control signals provided to the ventilator automatically control PEEP, and FIO2, for a next breath of the patient.
2. The apparatus ofclaim 1, wherein the first means comprises a programmable microcomputer.
3. The apparatus ofclaim 2, further comprising
an alarm unit;
wherein the first means further determines whether there has been an artifact in the measured oxygen levels and replaces and/or corrects the data determined to be based on the artifact; and
wherein the second means further provides an alarm control signal to the alarm unit to warn of the artifact in the measured oxygen levels.
4. The apparatus ofclaim 2, further comprising
an alarm unit;
wherein the first means further determines whether the measured oxygen levels are outside a prescribed range; and
wherein the second means further provides an alarm control signal to the alarm unit to warn of the measured oxygen level of the patient being outside a prescribed range.
5. The apparatus ofclaim 2, further comprising an analog to digital (A/D) converter connected to an input of the first means for converting analog signals from an oxygen sensor, indicative of the oxygen level of the patient, to digital data.
6. The apparatus ofclaim 5, wherein the oxygen sensor is a pulse oximeter measuring arterial hemoglobin oxygen saturation in the patient's blood.
7. The apparatus ofclaim 2, wherein data indicative of the lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is provided to the first means.
8. The apparatus ofclaim 7, wherein the data indicative of LIP is supplied by a monitor operatively coupled to the first means.
9. The apparatus ofclaim 2, wherein data indicative of the patient's measured intrinsic positive end-expiratory pressure (PEEPi) is provided to the first means.
10. The apparatus ofclaim 9, wherein the data indicative of PEEPi is supplied by a monitor operatively coupled to the first means.
11. The apparatus ofclaim 2, wherein the programmable microcomputer further comprises a program means for determining from the input data: the patient's arterial partial pressure of oxygen; the required FIO2; the required PEEP; for a next breath of the patient.
12. The apparatus ofclaim 11, wherein the program means further determines, from the input data: whether there has been an artifact in the data indicative of the measured oxygen level of the patient, and wherein the program means further replaces and/or corrects the data based on the artifact and generates a warning signal in the event the artifact is determined.
13. The apparatus ofclaim 2, wherein data corresponding to a set point for arterial partial pressure of oxygen, threshold values for the oxygen level of the patient, and a correction factor for oxygen based on measured blood pH levels of the patient are entered manually and stored in a software program.
14. The apparatus ofclaim 2, wherein the first means further processes input data indicative of respiratory elastance, respiratory airway resistance, barometric pressure, and measured carbon dioxide levels of the patient, and based upon the input data, provides digital output data indicative of required ventilation, optimum breathing frequency, and required adjustment in the ratio of inspiration time to expiration time (I:E) for a next breath of the patient, and; wherein the second means further generates additional control signals to the ventilator based on the output data of the first means; wherein the additional control signals to the ventilator control tidal volume and frequency of inhaled gas provided to the patient by the ventilator and effect necessary adjustments in the ratio of I:E for a next breath of the patient.
15. The apparatus ofclaim 14, wherein the input data indicative of respiratory elastance and airway resistance of the patient are supplied to the first means by one or more monitors coupled to the first means.
16. The apparatus ofclaim 14, wherein the input data indicative of respiratory elastance and airway resistance of the patient are entered manually and stored in a software program.
17. The apparatus ofclaim 14, wherein the input data indicative of the measured oxygen level of the patient and the measured carbon dioxide level of the patient are provided to the first means by one or more monitors coupled to the first means.
18. The apparatus ofclaim 17, wherein the input data indicative of the measured oxygen level of the patient is provided by a pulse oximeter measuring arterial hemoglobin oxygen saturation of the patient, and the input data indicative of the measured carbon dioxide level of the patient is provided by an exhaled gas analyzer detecting end-tidal partial pressure of carbon dioxide or end-tidal concentration of carbon dioxide in exhaled gas of the patient.
19. The apparatus ofclaim 17, wherein, based on data indicative of measured oxygen and carbon dioxide levels of the patient, the first means detects an artifact in the data, discards the data having the artifact, resumes a previous value of the data in a memory, and provides a warning instruction signal; and wherein the second means generates a warning control signal that is supplied to an alarm unit that generates an alarm signal.
20. The apparatus ofclaim 17, wherein, based on data indicative of measured carbon dioxide and oxygen levels of the patient, the first means detects a potential pulmonary embolism and produces digital output data indicative of predefined levels of ventilation and breathing frequency and a required adjustment in the I:E ratio, and provides a warning instruction signal; and wherein the second means generates a warning control signal.
21. The apparatus ofclaim 17, further comprising program means for determining from the input data: (i) partial pressures of oxygen and carbon dioxide in arterial blood of the patient; (ii) presence of artifact(s) in the data indicative of the measured oxygen and carbon dioxide levels of the patient, and in case of artifact detection, replacing and/or correcting the data and corresponding partial pressure value(s); (iii) net effects of oxygen and carbon dioxide on alveolar ventilation; (iv) total required alveolar ventilation; (v) optimal frequency of breathing; (vi) required ventilation; (vii) required adjustment in the I:E ratio; (viii) required FIO2; and (ix) required PEEP; for a next breath of the patient.
22. The apparatus ofclaim 21, wherein data corresponding to a set point for arterial partial pressure of oxygen, an adjustment factor for carbon dioxide level of the patient, threshold levels for oxygen level of the patient, and a correction factor for oxygen based on measured blood pH levels of the patient, are entered manually and stored in a software program.
23. The apparatus ofclaim 14, wherein the input data indicative of barometric pressure is supplied to the first means by one or more monitors coupled to the first means.
24. The apparatus ofclaim 14, wherein the input data indicative of barometric pressure is entered manually and stored in hardware.
25. The apparatus ofclaim 14, wherein the input data indicative of barometric pressure is entered manually and stored in a software program.
26. The apparatus ofclaim 14, wherein the first means also receives and processes data indicative of the patient's metabolic rate ratio.
27. The apparatus ofclaim 26, wherein the data indicative of the patient's metabolic rate ratio is supplied to the first means by a monitor coupled to the first means.
28. The apparatus ofclaim 26, wherein the data indicative of the patient's metabolic rate ratio is entered manually and stored in a software program.
29. A method for automatically controlling a ventilator comprising the steps of:
(a) measuring an oxygen level of a patient and providing a data signal indicative of the measured oxygen level;
(b) determining: (i) required concentration of oxygen in an inspiratory gas of the patient, FIO2, based on the data signal indicative of the measured oxygen level of the patient and to reduce the difference between the measured oxygen level of the patient and a desired value; (ii) required positive end-expiratory pressure, PEEP, wherein a ratio of PEEP/FIO2is maintained within a prescribed range, and to keep the measured oxygen level of the patient above a predefined value; and
(c) providing data signals indicative of the required FIO2and the required PEEP based upon the determining of step (b), for automatically controlling FIO2and PEEP for a next breath of the patient.
30. The method ofclaim 29, wherein step (b) further comprises determining, from the data indicative of the measured oxygen level in (a), whether there has been an artifact in the measured oxygen level, and replacing and/or correcting the data signal in (a) in the event the artifact is determined.
31. The method ofclaim 29, wherein the data signal indicative of measured oxygen level of the patient is in analog form and is converted to digital form before the determining of step (b), and wherein the providing of step (c) further comprises converting the data signals from digital to analog form.
32. The method ofclaim 31, wherein the measuring of the oxygen level of the patient comprises measuring an arterial hemoglobin oxygen saturation of the patient via pulse oximetry.
33. The method ofclaim 32, wherein an arterial partial pressure of oxygen of the patient is derived from the arterial hemoglobin oxygen saturation of the patient measured by the pulse oximeter.
34. The method ofclaim 33, wherein the following equation is used to calculate the arterial partial pressure of oxygen (PaO2) of the patient from the arterial hemoglobin oxygen saturation data (SpO2) measured by pulse oximetry:
PaO2=-ln[1-(SpO2)0.5]0.046+CP
where PaO2is in mm Hg and CP is a correction parameter which is used to shift PaO2and CP is based on the patient's measured blood pH level.
35. The method ofclaim 34, further comprising:
comparing PaO2to a minimum acceptable value, and,
if PaO2is found to be less than the minimum acceptable value:
discarding PaO2and a latest measured SpO2data;
resuming previous values of PaO2and SpO2; and
generating a warning signal.
36. The method ofclaim 29, wherein data corresponding to the lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is also provided in step (a), and an initial value for PEEP is set equal to LIP plus 0 to 8 cm H2O and the initial value for PEEP is provided in step (b).
37. The method ofclaim 36, wherein the data corresponding to LIP is supplied by a monitor.
38. The method ofclaim 29, wherein data corresponding to the measured intrinsic PEEP of the patient (PEEPi) is also provided in step (a), and an initial value for PEEP is set between 80% and 100% of PEEPi and the initial value for PEEP is provided in step (b).
39. The method ofclaim 38, wherein the data corresponding to PEEPi is supplied by a monitor.
40. The method ofclaim 29, wherein an initial value for PEEP is determined by the operator and is manually provided.
41. The method ofclaim 29, wherein the required concentration of oxygen in the inspiratory gas of the patient (FIO2) is calculated by using a stepwise control scheme and/or by using a proportional-integral-derivative (PID) technique.
42. The method ofclaim 41, wherein using a PID technique comprises comparing SpO2obtained by pulse oximetry to a defined minimum safe value, and wherein using the PID technique continues while SpO2is greater than the defined minimum safe value.
43. The method ofclaim 41, wherein using a PID technique comprises comparing SpO2obtained by pulse oximetry to a defined minimum safe value, and wherein, if SpO2is found to be less than or equal to the defined minimum safe value, a stepwise control scheme is followed that comprises the steps of:
raising FIO2stepwise to avoid hypoxemia,
allowing FIO2to remain high until SpO2rises to a second threshold value,
lowering FIO2stepwise,
comparing SpO2to a third threshold value,
lowering FIO2stepwise upon SpO2rising to the third threshold value,
comparing SpO2to a fourth threshold value,
returning control to the PID technique upon SpO2rising to the fourth threshold value.
44. The method ofclaim 41, wherein the difference between a PaO2set point and the PaO2of the patient is reduced by using a PID control procedure according to the following equations:

Y1(k)=PaO2(set-point)−PaO2

Y2(k)=[Y1(k)−Y1(k−1)]/T

Y3(k)=Y3(k−1)+TY1(k)

E(k)=αY1(k)+βY3(k)+γY2(k)

G(k)=E(k)+0.21
where Y1(k), Y2(k), and Y3(k) are the proportional, derivative, and integral components of error, respectively, E(k) is an error function, T is a sampling interval, G(k) is the required FIO2, and parameters α, β, and γ are PID coefficients.
45. The method ofclaim 41, wherein the determining of required PEEP of the patient comprises the following procedure:
comparing the PEEP/FIO2ratio to a defined minimum allowed value,
increasing PEEP by a fixed incremental value if the PEEP/FIO2ratio is lower than the defined minimum allowed value and the time elapsed since the last adjustment in PEEP is longer than or equal to a fixed defined interval T1,
comparing the PEEP/FIO2ratio with a defined maximum allowed value if the PEEP/FIO2ratio is not less than the defined minimum allowed value,
comparing SpO2with a defined value if the PEEP/FIO2ratio is less than the defined maximum allowed value,
increasing PEEP by a fixed incremental value if SpO2is less than the defined value and the time elapsed since the last adjustment in PEEP is longer than or equal to T1,
if the PEEP/FIO2ratio is not less than the defined maximum allowed value, comparing the PEEP/FIO2ratio to a value higher than the defined maximum allowed value, RG, whereby if the PEEP/FIO2ratio is higher than RG, and the time elapsed since the last adjustment in PEEP is greater than or equal to T1, decreasing PEEP by a fixed incremental amount.
46. An apparatus for automatically controlling a ventilator for a next breath of a patient comprising:
first means for processing input data indicative of at least a measured oxygen level of the patient, and for providing output data indicative of:
required concentration of oxygen in inspiratory gas of the patient (FIO2) and required positive end-expiratory pressure (PEEP) for a next breath of the patient,
wherein FIO2is determined to reduce the difference between the measured oxygen level of the patient and a desired value;
wherein a ratio of PEEP/FIO2is calculated and PEEP is determined to keep said ratio of PEEP/FIO2within one prescribed range;
wherein PEEP is determined without using a proportional-integral-derivative (PID) control procedure and while PEEP is determined to keep the ratio of PEEP/FIO2within one prescribed range, PEEP is determined to also keep the measured oxygen level of the patient above a predefined value; and
second means, operatively coupled to the first means, for providing control signals, based on the output data provided by the first means, to the ventilator for PEEP and to a mixer regulator, operatively coupled to the ventilator, for FIO2;
wherein the control signals automatically control PEEP and FIO2for a next breath of the patient.
47. The apparatus ofclaim 46, wherein the first means comprises a programmable microcomputer.
48. The apparatus ofclaim 47, further comprising an alarm unit;
wherein the first means further determines whether there has been an artifact in the measured oxygen level and in response to determining an artifact is present, replaces the measured oxygen level with the artifact with a most recent measured oxygen level without artifact; and
wherein the second means further provides an alarm control signal to the alarm unit in response to the determination by the first means that there has been an artifact to warn of an artifact in the current measured oxygen level.
49. The apparatus ofclaim 47, further comprising an alarm unit;
wherein the first means further determines whether the measured oxygen level is outside a prescribed range; and
wherein the second means further provides an alarm control signal to the alarm unit in response to the determination by the first means that the measured oxygen level is outside the prescribed range to warn of the measured oxygen level of the patient being outside the prescribed range.
50. The apparatus ofclaim 47, wherein the input data indicative of at least the measured oxygen level of the patient processed by the first means includes arterial hemoglobin oxygen saturation data measured by a pulse oximeter operatively coupled to the first means.
51. The apparatus ofclaim 47, wherein data indicative of a lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is provided to the first means.
52. The apparatus ofclaim 51, wherein the data indicative of LIP is supplied by a monitor operatively coupled to the first means.
53. The apparatus ofclaim 47, wherein data indicative of the patient's measured intrinsic positive end-expiratory pressure (PEEPi) is provided to the first means.
54. The apparatus ofclaim 53, wherein the data indicative of PEEPi is supplied by a monitor operatively coupled to the first means.
55. The apparatus ofclaim 47, wherein the programmable microcomputer further comprises a program means for determining from the input data:
a patient's arterial partial pressure of oxygen;
the required FIO2; and
the required PEEP
for a next breath of the patient.
56. The apparatus ofclaim 55, wherein the program means further determines, from the input data:
whether there has been an artifact in the measured oxygen level of the patient, and
wherein the program means, in response to determining an artifact is present, further replaces the measured oxygen level with the artifact with a most recent measured oxygen level without artifact, and
the apparatus further comprising alarm means for generating a warning signal in the event the artifact is determined to be present.
57. The apparatus ofclaim 47, wherein data corresponding to a set point for arterial partial pressure of oxygen, threshold values for arterial hemoglobin oxygen saturation level of the patient, and a correction factor for arterial partial pressure of oxygen based on measured blood pH levels of the patient are entered manually and stored in a software program.
58. The apparatus ofclaim 47, wherein input data indicative of at least a measured oxygen level of the patient which is processed by the first means further includes input data indicative of respiratory elastance, respiratory airway resistance, barometric pressure, and measured carbon dioxide level of the patient, and based upon the input data, the first means provides digital output data indicative of required ventilation, optimum breathing frequency, and required adjustment in the ratio of inspiration time to expiration time (I:E) for a next breath of the patient;
wherein the second means further generates additional control signals to the ventilator based on the digital output data of the first means; and
wherein the additional control signals to the ventilator control tidal volume and frequency of inhaled gas provided to the patient by the ventilator and effect necessary adjustments in the ratio of I:E for a next breath of the patient.
59. The apparatus ofclaim 58, wherein the input data indicative of respiratory elastance and airway resistance of the patient are supplied to the first means by one or more monitors coupled to the first means.
60. The apparatus ofclaim 58, wherein the input data indicative of respiratory elastance and airway resistance of the patient are entered manually and stored in a software program.
61. The apparatus ofclaim 58, wherein the input data indicative of the measured oxygen level of the patient and the measured carbon dioxide level of the patient are provided to the first means by one or more monitors coupled to the first means.
62. The apparatus ofclaim 61, wherein the input data indicative of the measured oxygen level of the patient is provided by a pulse oximeter measuring arterial hemoglobin oxygen saturation of the patient, and the input data indicative of the measured carbon dioxide level of the patient is provided by an exhaled gas analyzer detecting end-tidal partial pressure of carbon dioxide or end-tidal concentration of carbon dioxide in exhaled gas of the patient.
63. The apparatus ofclaim 61, wherein, based on the input data indicative of the measured oxygen level and the measured carbon dioxide level of the patient, the first means detects an artifact in the input data indicative of the measured oxygen level and/or the measured carbon dioxide level of the patient, discards the input data indicative of the measured oxygen level and/or the measured carbon dioxide level of the patient having the artifact, and resumes a value of data indicative of the most recent measured oxygen level without artifact and/or the most recent measured carbon dioxide level without artifact stored in a memory; and wherein the second means generates a warning control signal that is supplied to an alarm unit that generates an alarm signal.
64. The apparatus ofclaim 61, wherein, based on the input data indicative of the measured carbon dioxide level and the measured oxygen level of the patient, the first means detects a potential pulmonary embolism and produces digital output data indicative of predefined levels of ventilation and breathing frequency and a required adjustment in the I:E ratio, and provides a warning instruction signal; and wherein the second means generates a warning control signal in response to the warning instruction signal provided by the first means.
65. The apparatus ofclaim 61, wherein the first means comprises a first control program means for determining from the input data:
(i) partial pressures of oxygen and carbon dioxide in arterial blood of the patient;
(ii) presence of artifact(s) in the input data indicative of the measured oxygen level and/or carbon dioxide level of the patient, and in case of artifact detection, replacing the input data indicative of the measured oxygen level and/or carbon dioxide level of the patient with the artifact and corresponding partial pressure value with data indicative of most recent measured oxygen level without an artifact and/or the measured carbon dioxide level without artifact and corresponding partial pressure value(s);
(iii) net effects of oxygen and carbon dioxide on alveolar ventilation;
(iv) total required alveolar ventilation;
(v) the optimal frequency of breathing;
(vi) the required ventilation; and
(vii) the required adjustment in the I:E ratio
for a next breath of the patient; and
a second control program means for determining:
(i) the required FIO2; and
(ii) the required PEEP
for a next breath of the patient.
66. The apparatus ofclaim 65, wherein data corresponding to a set point for the arterial partial pressure of oxygen, an adjustment factor for the measured carbon dioxide level of the patient, threshold levels for arterial hemoglobin oxygen saturation level of the patient, and a correction factor for the arterial partial pressure of oxygen based on measured blood pH levels of the patient are entered manually and stored in a software program.
67. The apparatus ofclaim 58, wherein the input data indicative of barometric pressure is supplied to the first means by one or more monitors coupled to the first means.
68. The apparatus ofclaim 58, wherein the input data indicative of barometric pressure is entered manually and stored in hardware.
69. The apparatus ofclaim 58, wherein the input data indicative of barometric pressure is entered manually and stored in a software program.
70. The apparatus ofclaim 58, wherein the first means also receives and processes data indicative of the patient's metabolic rate ratio.
71. The apparatus ofclaim 70, wherein the data indicative of the patient's metabolic rate ratio is entered manually and stored in a software program.
72. A method for automatically controlling a ventilator for a next breath of a patient comprising the steps of:
(a) measuring an oxygen level of the patient and providing a data signal indicative of the measured oxygen level;
(b) determining for a next breath of the patient:
(i) required concentration of oxygen in an inspiratory gas of the patient, FIO2, based on the data signal indicative of the measured oxygen level of the patient, to reduce the difference between the measured oxygen level of the patient and a desired value; and
(ii) required positive end expiratory pressure, PEEP,
wherein a ratio of PEEP/FIO2is calculated and PEEP is determined to keep said ratio of PEEP/FIO2within one prescribed range,
wherein PEEP is determined without using a proportional-integral-derivative (PID) control procedure, and
while PEEP is determined to keep the ratio of PEEP/FIO2within one prescribed range, PEEP is determined to also keep the measured oxygen level of the patient above a predefined value; and
(c) providing data signals indicative of the required FIO2and the required PEEP, based upon the determining of step (b), for automatically controlling FIO2and PEEP for a next breath of the patient.
73. The method ofclaim 72, wherein step (b) further comprises determining, from the data signal indicative of the measured oxygen level in step (a), whether there has been an artifact in the measured oxygen level, and, in the event an artifact is determined, replacing the measured oxygen level with the artifact with a most recent measured oxygen level without artifact.
74. The method ofclaim 72, wherein the measuring of the oxygen level of the patient comprises measuring an arterial hemoglobin oxygen saturation of the patient via pulse oximetry.
75. The method ofclaim 74, wherein an arterial partial pressure of oxygen of the patient is derived from the arterial hemoglobin oxygen saturation of the patient (SpO2) measured by a pulse oximeter.
76. The method ofclaim 75, wherein the following equation is used to calculate the arterial partial pressure of oxygen (PaO2) of the patient from the arterial hemoglobin oxygen saturation data (SpO2) measured by pulse oximetry:
PaO2=-ln[1-(SpO2)0.5]0.046+CP
where PaO2is in mm Hg and CP is a correction parameter which is used to shift PaO2and CP is based on a measured blood pH level of the patient.
77. The method ofclaim 76, further comprising: comparing PaO2to a minimum acceptable value, and, if PaO2is found to be less than the minimum acceptable value, discarding the PaO2found to be less than the minimum acceptable value and a latest measured SpO2data corresponding thereto; resuming a most recent value of PaO2found to be equal to or greater than the minimum acceptable value and corresponding value of SpO2; and generating, by a signal generator, a warning signal.
78. The method ofclaim 72, wherein data corresponding to the lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is also provided in step (a), and an initial value for PEEP is set equal to LIP plus 0 to 8 cm H2O and the initial value for PEEP is provided in step (b).
79. The method ofclaim 78, wherein the data corresponding to LIP is supplied by a monitor.
80. The method ofclaim 72, wherein data corresponding to a measured intrinsic PEEP of the patient (PEEPi) is also provided in step (a), and an initial value for PEEP is set between 80% and 85% of PEEPi and the initial value for PEEP is provided in step (b).
81. The method ofclaim 80, wherein the data corresponding to PEEPi is supplied by a monitor.
82. The method ofclaim 72, wherein an initial value for PEEP is determined by the operator and is manually provided.
83. The method ofclaim 72, wherein the required concentration of oxygen in the inspiratory gas of the patient (FIO2) in step (b)(i) is calculated by using a stepwise control scheme and/or by using a proportional-integral-derivative (PID) control procedure.
84. The method ofclaim 83, wherein using the PID control procedure comprises comparing SpO2obtained by pulse oximetry to a defined minimum safe value, and wherein using the PID control procedure continues while SpO2is greater than the defined minimum safe value.
85. The method ofclaim 83, wherein using the PID control procedure comprises comparing SpO2obtained by pulse oximetry to a defined minimum safe value, and wherein, if SpO2is found to be less than or equal to the defined minimum safe value, the stepwise control scheme is followed and comprises the steps of:
raising FIO2stepwise to avoid hypoxemia,
allowing FIO2to remain high until SpO2rises to a second threshold value,
lowering FIO2stepwise,
comparing SpO2to a third threshold value,
lowering FIO2stepwise upon SpO2rising to the third threshold value,
comparing SpO2to a fourth threshold value,
returning control to the PID control procedure upon SpO2rising to the fourth threshold value.
86. The method ofclaim 83, wherein the difference between a PaO2set point and a PaO2of the patient is reduced by using the PID control procedure according to the following equations:

Y1(K)=PaO2(set-point)−PaO2

Y2(K)=[Y1(K)−Y1(K−1)]/T

Y3(K)=Y3(K−1)+TY1(K)

E(K)=αY1(K)+βY3(K)+γY2(K)

G(K)=E(K)+0.21
where Y1(k), Y2(k), and Y3(k) are the proportional, derivative, and integral components of error, respectively, E(k) is an error function, T is a sampling interval, G(k) is the required FIO2, and parameters α, β, and γ are PID coefficients.
87. The method ofclaim 83, wherein the determining of required PEEP of the patient comprises the following procedure:
comparing the PEEP/FIO2ratio to a defined minimum allowed value,
increasing PEEP by a fixed incremental value if the PEEP/FIO2ratio is lower than the defined minimum allowed value and a time elapsed since the last adjustment in PEEP is longer than or equal to a fixed defined interval T1,
comparing the PEEP/FIO2ratio with a defined maximum allowed value if the PEEP/FIO2ratio is not less than the defined minimum allowed value,
comparing SpO2with a defined value if the PEEP/FIO2ratio is less than the defined maximum allowed value,
increasing PEEP by a fixed incremental value if SpO2is less than the defined value and the time elapsed since the last adjustment in PEEP is longer than or equal to T1, if the PEEP/FIO2ratio is not less than the defined maximum allowed value, comparing the PEEP/FIO2ratio to a value higher than the defined maximum allowed value, RG, whereby if the PEEP/FIO2ratio is higher than RG, and the time elapsed since the last adjustment in PEEP is greater than or equal to T1, decreasing PEEP by a fixed incremental amount.
US17/727,0652003-11-212022-04-22Method and apparatus for controlling a ventilatorActive2029-07-29USRE50219E1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US17/727,065USRE50219E1 (en)2003-11-212022-04-22Method and apparatus for controlling a ventilator

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US48169303P2003-11-212003-11-21
US10/935,446US7802571B2 (en)2003-11-212004-09-07Method and apparatus for controlling a ventilator
US17/727,065USRE50219E1 (en)2003-11-212022-04-22Method and apparatus for controlling a ventilator

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US10/935,446ReissueUS7802571B2 (en)2003-11-212004-09-07Method and apparatus for controlling a ventilator

Publications (1)

Publication NumberPublication Date
USRE50219E1true USRE50219E1 (en)2024-11-26

Family

ID=34594521

Family Applications (2)

Application NumberTitlePriority DateFiling Date
US10/935,446CeasedUS7802571B2 (en)2003-11-212004-09-07Method and apparatus for controlling a ventilator
US17/727,065Active2029-07-29USRE50219E1 (en)2003-11-212022-04-22Method and apparatus for controlling a ventilator

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US10/935,446CeasedUS7802571B2 (en)2003-11-212004-09-07Method and apparatus for controlling a ventilator

Country Status (6)

CountryLink
US (2)US7802571B2 (en)
AU (1)AU2004292955B2 (en)
CA (1)CA2545570C (en)
GB (1)GB2423721B (en)
NZ (1)NZ546941A (en)
WO (1)WO2005051280A2 (en)

Families Citing this family (180)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE50015462D1 (en)*1999-04-072009-01-02Event Medical Ltd VENTILATOR
US9053222B2 (en)2002-05-172015-06-09Lawrence A. LynnPatient safety processor
WO2004075746A2 (en)2003-02-272004-09-10Cardiodigital LimitedMethod and system for analysing and processing ph0t0plethysmogram signals using wavelet transform
US7840270B2 (en)*2003-07-232010-11-23Synapse Biomedical, Inc.System and method for conditioning a diaphragm of a patient
US7802571B2 (en)2003-11-212010-09-28Tehrani Fleur TMethod and apparatus for controlling a ventilator
WO2005087097A1 (en)*2004-03-082005-09-22Masimo CorporationPhysiological parameter system
US20070044669A1 (en)*2005-08-242007-03-01Geise Gregory DAluminum can compacting mechanism with improved actuation handle assembly
US9050005B2 (en)*2005-08-252015-06-09Synapse Biomedical, Inc.Method and apparatus for transgastric neurostimulation
US20070077200A1 (en)*2005-09-302007-04-05Baker Clark RMethod and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes
CA2631915A1 (en)*2005-12-022007-06-07Synapse Biomedical, Inc.Transvisceral neurostimulation mapping device and method
ATE479460T1 (en)*2006-01-302010-09-15Hamilton Medical Ag O2 CONTROL
EP1996284A2 (en)*2006-03-092008-12-03Synapse Biomedical, Inc.Ventilatory assist system and method to improve respiratory function
US7909033B2 (en)2006-05-032011-03-22Comedica IncorporatedBreathing treatment apparatus
US8667963B2 (en)*2006-05-162014-03-11Impact Instrumentation, Inc.Ventilator circuit for oxygen generating system
US8051854B2 (en)*2006-09-152011-11-08Comedica IncorporatedContinuous high-frequency oscillation breathing treatment apparatus
US20080066752A1 (en)*2006-09-202008-03-20Nellcor Puritan Bennett Inc.Method and system for circulatory delay compensation in closed-loop control of a medical device
US8728059B2 (en)*2006-09-292014-05-20Covidien LpSystem and method for assuring validity of monitoring parameter in combination with a therapeutic device
CN101641047B (en)*2006-11-162011-10-05汉密尔顿医疗股份公司Method and device for determining the peep during the respiration of a patient
EP1930043B8 (en)2006-12-052018-06-27Löwenstein Medical Technology S.A.Method for determining oxygen concentration in a breathing gas mixture
CA2676119C (en)2007-01-292021-01-19Simon Fraser UniversityTransvascular nerve stimulation apparatus and methods
US9079016B2 (en)*2007-02-052015-07-14Synapse Biomedical, Inc.Removable intramuscular electrode
US20080202519A1 (en)*2007-02-232008-08-28General Electric CompanySetting mandatory mechanical ventilation parameters based on patient physiology
US20080202520A1 (en)*2007-02-232008-08-28General Electric CompanySetting mandatory mechanical ventilation parameters based on patient physiology
US20080202518A1 (en)*2007-02-232008-08-28General Electric CompanySetting mandatory mechanical ventilation parameters based on patient physiology
US20080202521A1 (en)*2007-02-232008-08-28General Electric CompanySetting mandatory mechanical ventilation parameters based on patient physiology
EP1961438A1 (en)2007-02-232008-08-27The General Electric CompanyInhalation anaesthesia delivery system and method
US20080202517A1 (en)*2007-02-232008-08-28General Electric CompanySetting madatory mechanical ventilation parameters based on patient physiology
US20080230060A1 (en)*2007-03-232008-09-25General Electric CompanySetting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
US20080230063A1 (en)*2007-03-232008-09-25General Electric CompanySetting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time
US20080230064A1 (en)*2007-03-232008-09-25General Electric CompanySetting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080230061A1 (en)*2007-03-232008-09-25General Electric CompanySetting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US8695593B2 (en)*2007-03-312014-04-15Fleur T. TehraniWeaning and decision support system for mechanical ventilation
US8316849B2 (en)*2007-04-262012-11-27Buxco Electronics, Inc.Integrated ventilator with calibration
US9820671B2 (en)*2007-05-172017-11-21Synapse Biomedical, Inc.Devices and methods for assessing motor point electromyogram as a biomarker
US9050434B2 (en)*2007-05-182015-06-09Comedica IncorporatedLung therapy device
EP3871722A1 (en)2007-07-182021-09-01Vapotherm, Inc.System for delivering a heated and humidified gas
US8905023B2 (en)2007-10-052014-12-09Vapotherm, Inc.Hyperthermic humidification system
US8428726B2 (en)2007-10-302013-04-23Synapse Biomedical, Inc.Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US8478412B2 (en)*2007-10-302013-07-02Synapse Biomedical, Inc.Method of improving sleep disordered breathing
US9078984B2 (en)*2008-01-312015-07-14Massachusetts Institute Of TechnologyMechanical ventilator
EP2257328A2 (en)2008-03-272010-12-08Nellcor Puritan Bennett LLCBreathing assistance systems with lung recruitment maneuvers
US8272380B2 (en)2008-03-312012-09-25Nellcor Puritan Bennett, LlcLeak-compensated pressure triggering in medical ventilators
US8746248B2 (en)2008-03-312014-06-10Covidien LpDetermination of patient circuit disconnect in leak-compensated ventilatory support
US8425428B2 (en)2008-03-312013-04-23Covidien LpNitric oxide measurements in patients using flowfeedback
US8267085B2 (en)2009-03-202012-09-18Nellcor Puritan Bennett LlcLeak-compensated proportional assist ventilation
US10207069B2 (en)2008-03-312019-02-19Covidien LpSystem and method for determining ventilator leakage during stable periods within a breath
US8251876B2 (en)2008-04-222012-08-28Hill-Rom Services, Inc.Breathing exercise apparatus
US20140244303A1 (en)2013-02-282014-08-28Lawrence A. LynnParallel Human Time Matrix Image of Causation
JP5474937B2 (en)2008-05-072014-04-16ローレンス エー. リン, Medical disorder pattern search engine
US8457706B2 (en)2008-05-162013-06-04Covidien LpEstimation of a physiological parameter using a neural network
WO2009149357A1 (en)2008-06-062009-12-10Nellcor Puritan Bennett LlcSystems and methods for ventilation in proportion to patient effort
US8398555B2 (en)*2008-09-102013-03-19Covidien LpSystem and method for detecting ventilatory instability
US8551006B2 (en)*2008-09-172013-10-08Covidien LpMethod for determining hemodynamic effects
WO2010036816A1 (en)2008-09-252010-04-01Nellcor Puritan Bennett LlcInversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators
US8652064B2 (en)*2008-09-302014-02-18Covidien LpSampling circuit for measuring analytes
US8302602B2 (en)2008-09-302012-11-06Nellcor Puritan Bennett LlcBreathing assistance system with multiple pressure sensors
US9011347B2 (en)2008-10-032015-04-21Nellcor Puritan Bennett IrelandMethods and apparatus for determining breathing effort characteristics measures
US9155493B2 (en)2008-10-032015-10-13Nellcor Puritan Bennett IrelandMethods and apparatus for calibrating respiratory effort from photoplethysmograph signals
DE102009013396B3 (en)2009-03-162010-08-05Dräger Medical AG & Co. KG Apparatus and method for controlling the oxygen dosage of a ventilator
US8428672B2 (en)*2009-01-292013-04-23Impact Instrumentation, Inc.Medical ventilator with autonomous control of oxygenation
US8424521B2 (en)2009-02-272013-04-23Covidien LpLeak-compensated respiratory mechanics estimation in medical ventilators
US20100224191A1 (en)*2009-03-062010-09-09Cardinal Health 207, Inc.Automated Oxygen Delivery System
US10426906B2 (en)2009-03-182019-10-01Mayo Foundation For Medical Education And ResearchVentilator monitoring and control
US8418691B2 (en)2009-03-202013-04-16Covidien LpLeak-compensated pressure regulated volume control ventilation
US8408203B2 (en)*2009-04-302013-04-02General Electric CompanySystem and methods for ventilating a patient
US8550077B2 (en)*2009-05-192013-10-08The Cleveland Clinic FoundationVentilator control system utilizing a mid-frequency ventilation pattern
US8444570B2 (en)*2009-06-092013-05-21Nellcor Puritan Bennett IrelandSignal processing techniques for aiding the interpretation of respiration signals
US20100331716A1 (en)*2009-06-262010-12-30Nellcor Puritan Bennett IrelandMethods and apparatus for measuring respiratory function using an effort signal
US20100331715A1 (en)*2009-06-302010-12-30Nellcor Puritan Bennett IrelandSystems and methods for detecting effort events
US8701665B2 (en)*2009-07-252014-04-22Fleur T TehraniAutomatic control system for mechanical ventilation for active or passive subjects
US8755854B2 (en)2009-07-312014-06-17Nellcor Puritan Bennett IrelandMethods and apparatus for producing and using lightly filtered photoplethysmograph signals
US8596270B2 (en)*2009-08-202013-12-03Covidien LpSystems and methods for controlling a ventilator
US8789529B2 (en)2009-08-202014-07-29Covidien LpMethod for ventilation
US9151425B2 (en)*2009-11-022015-10-06Comedica IncorporatedMultiple conduit connector apparatus and method
US20110100360A1 (en)*2009-11-022011-05-05Joseph Dee FaramComposite lung therapy device and method
US8638200B2 (en)*2010-05-072014-01-28Covidien LpVentilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient
JP2013533760A (en)*2010-06-102013-08-29オリディオン メディカル 1987 リミテッド Weaning from artificial respiration using capnography
US8607788B2 (en)2010-06-302013-12-17Covidien LpVentilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component
US8607790B2 (en)2010-06-302013-12-17Covidien LpVentilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component
US8607791B2 (en)2010-06-302013-12-17Covidien LpVentilator-initiated prompt regarding auto-PEEP detection during pressure ventilation
US8607789B2 (en)2010-06-302013-12-17Covidien LpVentilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component
US8676285B2 (en)2010-07-282014-03-18Covidien LpMethods for validating patient identity
US8834378B2 (en)2010-07-302014-09-16Nellcor Puritan Bennett IrelandSystems and methods for determining respiratory effort
US8554298B2 (en)2010-09-212013-10-08Cividien LPMedical ventilator with integrated oximeter data
AU2011333436B2 (en)*2010-11-232016-08-04Koninklijke Philips Electronics N.V.Obesity hypoventilation syndrome treatment system and method
US8757153B2 (en)2010-11-292014-06-24Covidien LpVentilator-initiated prompt regarding detection of double triggering during ventilation
US8595639B2 (en)2010-11-292013-11-26Covidien LpVentilator-initiated prompt regarding detection of fluctuations in resistance
US8757152B2 (en)2010-11-292014-06-24Covidien LpVentilator-initiated prompt regarding detection of double triggering during a volume-control breath type
JP6235342B2 (en)*2010-12-172017-11-22コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. System for customizable automatic control of inhaled oxygen fraction and / or positive end expiratory pressure to maintain oxygenation
US9038633B2 (en)2011-03-022015-05-26Covidien LpVentilator-initiated prompt regarding high delivered tidal volume
US8714154B2 (en)2011-03-302014-05-06Covidien LpSystems and methods for automatic adjustment of ventilator settings
US8776792B2 (en)2011-04-292014-07-15Covidien LpMethods and systems for volume-targeted minimum pressure-control ventilation
US8801619B2 (en)2011-06-302014-08-12Covidien LpPhotoplethysmography for determining ventilation weaning readiness
US9089657B2 (en)2011-10-312015-07-28Covidien LpMethods and systems for gating user initiated increases in oxygen concentration during ventilation
US9364624B2 (en)2011-12-072016-06-14Covidien LpMethods and systems for adaptive base flow
US9498589B2 (en)2011-12-312016-11-22Covidien LpMethods and systems for adaptive base flow and leak compensation
US9022031B2 (en)2012-01-312015-05-05Covidien LpUsing estimated carinal pressure for feedback control of carinal pressure during ventilation
US9180271B2 (en)2012-03-052015-11-10Hill-Rom Services Pte. Ltd.Respiratory therapy device having standard and oscillatory PEP with nebulizer
IN2014MN01970A (en)2012-03-052015-07-03Univ Fraser Simon
US9024756B2 (en)*2012-03-282015-05-05J And N Enterprises Inc.Immediate detection system and method thereof
US8844526B2 (en)2012-03-302014-09-30Covidien LpMethods and systems for triggering with unknown base flow
JP6195897B2 (en)*2012-03-302017-09-13コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. System and readable storage medium for real-time evaluation of respiratory capacity and closed-loop feedback control
JP6490577B2 (en)2012-04-172019-03-27マシモ・コーポレイション How to operate a pulse oximeter device
US9993604B2 (en)2012-04-272018-06-12Covidien LpMethods and systems for an optimized proportional assist ventilation
EP2863987B1 (en)2012-06-212023-08-02Lungpacer Medical Inc.Transvascular diaphragm pacing systems
US10362967B2 (en)2012-07-092019-07-30Covidien LpSystems and methods for missed breath detection and indication
US9027552B2 (en)2012-07-312015-05-12Covidien LpVentilator-initiated prompt or setting regarding detection of asynchrony during ventilation
EP2895223B1 (en)*2012-09-122019-05-22Maquet Critical Care ABAn anesthesia system, a method and a computer-readable medium for actively controlling oxygen delivered to a patient
US9375542B2 (en)2012-11-082016-06-28Covidien LpSystems and methods for monitoring, managing, and/or preventing fatigue during ventilation
US10354429B2 (en)2012-11-142019-07-16Lawrence A. LynnPatient storm tracker and visualization processor
US9953453B2 (en)2012-11-142018-04-24Lawrence A. LynnSystem for converting biologic particle density data into dynamic images
US12080401B2 (en)2012-12-032024-09-03Metrohealth Ventures LlcCombination respiratory therapy device, system and method
US9795752B2 (en)2012-12-032017-10-24Mhs Care-Innovation, LlcCombination respiratory therapy device, system, and method
US9492629B2 (en)2013-02-142016-11-15Covidien LpMethods and systems for ventilation with unknown exhalation flow and exhalation pressure
US9358355B2 (en)2013-03-112016-06-07Covidien LpMethods and systems for managing a patient move
US9981096B2 (en)2013-03-132018-05-29Covidien LpMethods and systems for triggering with unknown inspiratory flow
US10449311B2 (en)2013-06-052019-10-22Thornhill Scientific Inc.Controlling arterial blood gas concentration
EP3003446A4 (en)*2013-06-052017-01-11Michael KleinControlling arterial blood gas concentration
US9675771B2 (en)2013-10-182017-06-13Covidien LpMethods and systems for leak estimation
US10022068B2 (en)2013-10-282018-07-17Covidien LpSystems and methods for detecting held breath events
CN105873630B (en)2013-11-222020-01-03隆佩瑟尔医疗公司Device and method for assisted respiration by transvascular nerve stimulation
AU2015208640B2 (en)2014-01-212020-02-20Lungpacer Medical Inc.Systems and related methods for optimization of multi-electrode nerve pacing
WO2015136405A1 (en)*2014-03-112015-09-17Koninklijke Philips N.V.Reducing hypercapnic respiratory failure during mechanical ventilation
US9839760B2 (en)*2014-04-112017-12-12Vyaire Medical Capital LlcMethods for controlling mechanical lung ventilation
US10183139B2 (en)2014-04-112019-01-22Vyaire Medical Capital LlcMethods for controlling mechanical lung ventilation
US9956365B2 (en)2014-04-112018-05-01Vyaire Medical Capital LlcLung ventilation apparatus
US9808591B2 (en)2014-08-152017-11-07Covidien LpMethods and systems for breath delivery synchronization
US20160058346A1 (en)*2014-09-022016-03-03General Electric CompanyDetermination of arterial co2 partial pressure
US9950129B2 (en)2014-10-272018-04-24Covidien LpVentilation triggering using change-point detection
US10596345B2 (en)2014-12-312020-03-24Vapotherm, Inc.Systems and methods for humidity control
JP6865686B2 (en)*2014-12-312021-04-28コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. A system that performs histogram analysis of time-based capnography signals and how it works
US9925346B2 (en)2015-01-202018-03-27Covidien LpSystems and methods for ventilation with unknown exhalation flow
US10007238B1 (en)2015-01-222018-06-26John C. TaubeOxygen mixing and delivery
DE102015103894A1 (en)*2015-03-172016-09-22Fritz Stephan Gmbh Medizintechnik Respirators and control methods for ventilators
CN104834326B (en)*2015-04-012017-12-19深圳市科曼医疗设备有限公司Lung ventilator oxygen concentration control method, device and system
EP4186548A1 (en)2015-04-022023-05-31Hill-Rom Services PTE. LTD.Mask leakage detection for a respiratory device
BR112017027846A2 (en)*2015-06-242019-02-12Chris Salvino oxygen bioremediation devices and methods
ES2933699T3 (en)*2015-11-102023-02-13Univ Tasmania Method, apparatus and system for automatically controlling the inspired oxygen supply
JP7186174B2 (en)*2016-12-052022-12-08メディパインズ コーポレイション Systems and methods for respiration measurements using respiratory gas samples
US10357624B2 (en)*2016-12-062019-07-23Iasset AgVentilator apparatus and method for operating a ventilator in said ventilator apparatus
US11351320B2 (en)2017-02-222022-06-07Koninklijke Philips N.V.Automatic PEEP selection for mechanical ventilation
US10293164B2 (en)2017-05-262019-05-21Lungpacer Medical Inc.Apparatus and methods for assisted breathing by transvascular nerve stimulation
CN111163834A (en)2017-06-302020-05-15隆佩瑟尔医疗公司Device for preventing, reducing and/or treating cognitive impairment
US10195429B1 (en)2017-08-022019-02-05Lungpacer Medical Inc.Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10940308B2 (en)2017-08-042021-03-09Lungpacer Medical Inc.Systems and methods for trans-esophageal sympathetic ganglion recruitment
SG11202002927YA (en)2017-10-062020-04-29Fisher & Paykel Healthcare LtdClosed loop oxygen control
AU2018353928B2 (en)2017-11-142019-06-13Covidien LpMethods and systems for drive pressure spontaneous ventilation
US20190175908A1 (en)2017-12-112019-06-13Lungpacer Medical Inc.Systems and methods for strengthening a respiratory muscle
WO2019222258A1 (en)2018-05-142019-11-21Covidien LpSystems and methods for respiratory effort detection utilizing signal distortion
CN108904938B (en)*2018-07-202024-03-22张锦洪Simple respirator device with function of accurately measuring tidal volume
US11517691B2 (en)2018-09-072022-12-06Covidien LpMethods and systems for high pressure controlled ventilation
EP3856362B1 (en)*2018-09-252024-08-283M Innovative Properties CompanyDynamically determining safety equipment for dynamically changing environments
US11752287B2 (en)2018-10-032023-09-12Covidien LpSystems and methods for automatic cycling or cycling detection
EP4548964A1 (en)2018-11-082025-05-07Lungpacer Medical Inc.Stimulation systems and related user interfaces
EP3884981B1 (en)*2018-11-232024-07-10Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Positive end expiratory pressure determining apparatus
CN111888599B (en)*2018-12-102022-10-04深圳市科曼医疗设备有限公司Pressure maintaining device of breathing machine
US11471683B2 (en)2019-01-292022-10-18Synapse Biomedical, Inc.Systems and methods for treating sleep apnea using neuromodulation
US20220133223A1 (en)*2019-02-152022-05-05Children's Medical Center CorporationSummarial scores for an emr platform
CN111694382B (en)*2019-03-152024-06-25欧姆龙健康医疗(中国)有限公司Gas supply concentration adjusting method, gas supply concentration adjusting system and oxygenerator
WO2020232333A1 (en)2019-05-162020-11-19Lungpacer Medical Inc.Systems and methods for sensing and stimulation
WO2020252037A1 (en)2019-06-122020-12-17Lungpacer Medical Inc.Circuitry for medical stimulation systems
US11324954B2 (en)2019-06-282022-05-10Covidien LpAchieving smooth breathing by modified bilateral phrenic nerve pacing
DE102019120307A1 (en)*2019-07-262021-01-28Forschungszentrum Borstel, Leibniz Lungenzentrum Device for supporting ventilation of a living being and computer program
WO2021026621A1 (en)*2019-08-122021-02-18Britto Azevedo Schneider FelipePressure and flow generator for mechanical veterinary pulmonary ventilation
CN114450053A (en)2019-09-102022-05-06费雪派克医疗保健有限公司 Methods and systems for controlling oxygen delivery in flow therapy devices
US20230022107A1 (en)*2019-10-252023-01-26Fisher & Paykel Healthcare LimitedAlarm for respiratory therapy system
US11779720B2 (en)2019-11-042023-10-10Vapotherm, Inc.Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery
US12070554B2 (en)2019-11-112024-08-27Hill-Rom Services Pte. Ltd.Pneumatic connector apparatus and method
US11612706B2 (en)2019-11-252023-03-28John C. TaubeMethods, systems, and devices for controlling mechanical ventilation
US11813399B2 (en)2019-11-282023-11-14Liauna KellyContinuous positive airway pressure (CPAP) apparatus and system
DE102021000313A1 (en)*2020-02-062021-08-12Löwenstein Medical Technology S.A. Method for operating a ventilator for artificial ventilation of a patient and such a ventilator
US12064562B2 (en)2020-03-122024-08-20Vapotherm, Inc.Respiratory therapy unit with non-contact sensing and control
US12257437B2 (en)2020-09-302025-03-25Covidien LpIntravenous phrenic nerve stimulation lead
CN112316264B (en)*2020-11-242024-09-17方梁Wall breathing oxygen automatic device for hospital
EP4313226A1 (en)*2021-03-302024-02-07Zoll Medical CorporationClosed loop control in mechanical ventilation
CN117642203A (en)*2021-12-272024-03-01深圳迈瑞生物医疗电子股份有限公司Ventilation control method and device
CN114588443A (en)*2022-03-092022-06-07北京航空航天大学江西研究院景德镇分院Intranasal high flow oxygen therapy intelligent regulation system based on lung imaging
DE102022117141A1 (en)2022-07-082024-01-11Löwenstein Medical Technology Sa Ventilator and method for supplying breathing gas
CN115887841B (en)*2022-08-192024-08-20湖南万脉医疗科技有限公司Breathing machine flow control method based on sleep state and sleep breathing machine
CN118748073A (en)*2024-07-182024-10-08陕西中医药大学第二附属医院 Surgery optimization method and system based on breathing tube condensation detection

Citations (52)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2414747A (en)1942-07-021947-01-21Harry M KirschbaumMethod and apparatus for controlling the oxygen content of the blood of living animals
GB835192A (en)1958-08-061960-05-18Philip Lockland StantonPressure breathing therapy apparatus
US3734091A (en)1971-06-221973-05-22Airco IncOxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US4121578A (en)1976-10-041978-10-24The Bendix CorporationPhysiological responsive control for an oxygen regulator
US4326513A (en)1979-07-021982-04-27Dragerwerk AgPatient data controlled respiration system
EP0099283A1 (en)1982-07-131984-01-25Compagnie Francaise De Produits OxygenesRespiratory insufficiency treatment device
US4448192A (en)1982-03-051984-05-15Hewlett Packard CompanyMedical ventilator device parametrically controlled for patient ventilation
US4584996A (en)1984-03-121986-04-29Blum Alvin SApparatus for conservative supplemental oxygen therapy
US4665911A (en)1983-11-251987-05-19Electro-FluidicsIntermittent supplemental oxygen apparatus and method
US4773411A (en)1986-05-081988-09-27Downs John BMethod and apparatus for ventilatory therapy
EP0303502A1 (en)1987-08-141989-02-15Btg International LimitedMotion artefact rejection system for pulse oximeters
US4889116A (en)1987-11-171989-12-26Phospho Energetics, Inc.Adaptive control of neonatal fractional inspired oxygen
US4986268A (en)1988-04-061991-01-22Tehrani Fleur TMethod and apparatus for controlling an artificial respirator
US5103814A (en)1988-04-281992-04-14Timothy MaherSelf-compensating patient respirator
US5315990A (en)1991-12-301994-05-31Mondry Adolph JMethod for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels
DE4309923A1 (en)1993-03-261994-09-29Boesch WilhelmApparatus arrangement for supplying respiration gas to a patient
US5365922A (en)*1991-03-191994-11-22Brigham And Women's Hospital, Inc.Closed-loop non-invasive oxygen saturation control system
US5388575A (en)*1992-09-251995-02-14Taube; John C.Adaptive controller for automatic ventilators
US5402796A (en)1990-09-191995-04-04University Of MelbourneArterial CO2 Monitor and closed loop controller
EP0658331A1 (en)1993-12-111995-06-21Hewlett-Packard GmbHA method for detecting an irregular state in a non-invasive pulse oximeter system
US5558086A (en)1992-12-161996-09-24Freedom Air ServicesMethod and apparatus for the intermittent delivery of oxygen therapy to a person
US5575283A (en)1994-02-141996-11-19Siemens-Elema AbDevice for determining an opening pressure in the lungs
US5617846A (en)1994-09-081997-04-08Gottlieb Weinmann Gerate Fur Medizin Und Arbeitsschutz Gmbh & Co.Method of controlling a respirator for treatment of sleep apnea and device for carrying out the method
US5682877A (en)1991-12-301997-11-04Mondry; Adolph J.System and method for automatically maintaining a blood oxygen saturation level
US5692497A (en)1996-05-161997-12-02Children's Medical Center CorporationMicroprocessor-controlled ventilator system and methods
US5705735A (en)*1996-08-091998-01-06Medical Graphics CorporationBreath by breath nutritional requirements analyzing system
US5738090A (en)1995-06-021998-04-14Burkhard LachmannRespiratory system for determining an opening pressure of a long system and maintaining the lung system open
US5752509A (en)1995-07-101998-05-19Burkhard LachmannArtificial ventilation system
WO1999004841A1 (en)1997-07-251999-02-04Minnesota Innovative Technologies & Instruments Corporation (Miti)Control device for supplying supplemental respiratory oxygen
US5937854A (en)1998-01-061999-08-17Sensormedics CorporationVentilator pressure optimization method and apparatus
WO1999061088A1 (en)1998-05-221999-12-02Resmed LimitedVentilatory assistance for treatment of cardiac failure and cheyne-stokes breathing
US6105575A (en)1994-06-032000-08-22Respironics, Inc.Method and apparatus for providing positive airway pressure to a patient
US6116241A (en)1996-07-082000-09-12Siemens-Elema AbMethod and apparatus for determining when a partially or completely collapsed lung has been opened
US6148814A (en)1996-02-082000-11-21Ihc Health Services, IncMethod and system for patient monitoring and respiratory assistance control through mechanical ventilation by the use of deterministic protocols
US6158432A (en)1995-12-082000-12-12Cardiopulmonary CorporationVentilator control system and method
US6305374B1 (en)1989-09-222001-10-23Respironics, Inc.Breathing gas delivery method and apparatus
US6355002B1 (en)2000-05-222002-03-12Comedica Technologies IncorporatedLung inflection point monitor apparatus and method
US6371114B1 (en)1998-07-242002-04-16Minnesota Innovative Technologies & Instruments CorporationControl device for supplying supplemental respiratory oxygen
US6390091B1 (en)1999-02-032002-05-21University Of FloridaMethod and apparatus for controlling a medical ventilator
US20020110849A1 (en)1999-01-282002-08-15Steffen LeonhardtNon-invasive method for optimizing the respiration of atelectatic lungs
US6512938B2 (en)2000-12-122003-01-28Nelson R. ClaureSystem and method for closed loop controlled inspired oxygen concentration
US6532958B1 (en)1997-07-252003-03-18Minnesota Innovative Technologies & Instruments CorporationAutomated control and conservation of supplemental respiratory oxygen
US20030060725A1 (en)2001-09-272003-03-27Kline Jeffrey A.Non-invasive device and method for the diagnosis of pulmonary vascular occlusions
US6578575B1 (en)1998-04-032003-06-17Siemens Elema AbMethod and apparatus for optimization of mechanical ventilation
US20030111078A1 (en)2001-06-212003-06-19Habashi Nader MaherVentilation method and control of a ventilator based on same
US6655382B1 (en)1997-09-182003-12-02The United States Of America As Represented By The Secretary Of Health And Human ServicesSpontaneous breathing apparatus and method
US6668829B2 (en)1995-12-082003-12-30Cardiopulmonary CorporationSystem for automatically weaning a patient from a ventilator, and method thereof
US20040003813A1 (en)*1999-06-302004-01-08Banner Michael J.Medical ventilator and method of controlling same
US6752151B2 (en)2000-09-252004-06-22Respironics, Inc.Method and apparatus for providing variable positive airway pressure
US20050051168A1 (en)*2003-08-042005-03-10Devries Douglas F.Portable ventilator system
US20070000494A1 (en)1999-06-302007-01-04Banner Michael JVentilator monitor system and method of using same
US7802571B2 (en)2003-11-212010-09-28Tehrani Fleur TMethod and apparatus for controlling a ventilator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5532958A (en)*1990-06-251996-07-02Dallas Semiconductor Corp.Dual storage cell memory
US6355022B1 (en)*1998-05-012002-03-12The Procter & Gamble CompanyAbsorbent interlabial device with substance thereon for maintaining the device in position
US6390940B1 (en)*1998-12-012002-05-21William NaullsBasketball game, apparatus and method of play

Patent Citations (59)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2414747A (en)1942-07-021947-01-21Harry M KirschbaumMethod and apparatus for controlling the oxygen content of the blood of living animals
GB835192A (en)1958-08-061960-05-18Philip Lockland StantonPressure breathing therapy apparatus
US3734091A (en)1971-06-221973-05-22Airco IncOxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US4121578A (en)1976-10-041978-10-24The Bendix CorporationPhysiological responsive control for an oxygen regulator
US4326513A (en)1979-07-021982-04-27Dragerwerk AgPatient data controlled respiration system
US4448192A (en)1982-03-051984-05-15Hewlett Packard CompanyMedical ventilator device parametrically controlled for patient ventilation
EP0099283A1 (en)1982-07-131984-01-25Compagnie Francaise De Produits OxygenesRespiratory insufficiency treatment device
US4665911A (en)1983-11-251987-05-19Electro-FluidicsIntermittent supplemental oxygen apparatus and method
US4584996A (en)1984-03-121986-04-29Blum Alvin SApparatus for conservative supplemental oxygen therapy
US4773411A (en)1986-05-081988-09-27Downs John BMethod and apparatus for ventilatory therapy
EP0303502A1 (en)1987-08-141989-02-15Btg International LimitedMotion artefact rejection system for pulse oximeters
US4889116A (en)1987-11-171989-12-26Phospho Energetics, Inc.Adaptive control of neonatal fractional inspired oxygen
US4986268A (en)1988-04-061991-01-22Tehrani Fleur TMethod and apparatus for controlling an artificial respirator
US5103814A (en)1988-04-281992-04-14Timothy MaherSelf-compensating patient respirator
US6539940B2 (en)1989-09-222003-04-01Respironics, Inc.Breathing gas delivery method and apparatus
US6305374B1 (en)1989-09-222001-10-23Respironics, Inc.Breathing gas delivery method and apparatus
US5402796A (en)1990-09-191995-04-04University Of MelbourneArterial CO2 Monitor and closed loop controller
US5365922A (en)*1991-03-191994-11-22Brigham And Women's Hospital, Inc.Closed-loop non-invasive oxygen saturation control system
US5682877A (en)1991-12-301997-11-04Mondry; Adolph J.System and method for automatically maintaining a blood oxygen saturation level
US5315990A (en)1991-12-301994-05-31Mondry Adolph JMethod for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels
US5388575A (en)*1992-09-251995-02-14Taube; John C.Adaptive controller for automatic ventilators
US5558086A (en)1992-12-161996-09-24Freedom Air ServicesMethod and apparatus for the intermittent delivery of oxygen therapy to a person
DE4309923A1 (en)1993-03-261994-09-29Boesch WilhelmApparatus arrangement for supplying respiration gas to a patient
EP0658331A1 (en)1993-12-111995-06-21Hewlett-Packard GmbHA method for detecting an irregular state in a non-invasive pulse oximeter system
US5575283A (en)1994-02-141996-11-19Siemens-Elema AbDevice for determining an opening pressure in the lungs
US6105575A (en)1994-06-032000-08-22Respironics, Inc.Method and apparatus for providing positive airway pressure to a patient
US5617846A (en)1994-09-081997-04-08Gottlieb Weinmann Gerate Fur Medizin Und Arbeitsschutz Gmbh & Co.Method of controlling a respirator for treatment of sleep apnea and device for carrying out the method
US5738090A (en)1995-06-021998-04-14Burkhard LachmannRespiratory system for determining an opening pressure of a long system and maintaining the lung system open
US5752509A (en)1995-07-101998-05-19Burkhard LachmannArtificial ventilation system
US6668829B2 (en)1995-12-082003-12-30Cardiopulmonary CorporationSystem for automatically weaning a patient from a ventilator, and method thereof
US6158432A (en)1995-12-082000-12-12Cardiopulmonary CorporationVentilator control system and method
US6148814A (en)1996-02-082000-11-21Ihc Health Services, IncMethod and system for patient monitoring and respiratory assistance control through mechanical ventilation by the use of deterministic protocols
US5692497A (en)1996-05-161997-12-02Children's Medical Center CorporationMicroprocessor-controlled ventilator system and methods
US6116241A (en)1996-07-082000-09-12Siemens-Elema AbMethod and apparatus for determining when a partially or completely collapsed lung has been opened
US5705735A (en)*1996-08-091998-01-06Medical Graphics CorporationBreath by breath nutritional requirements analyzing system
WO1999004841A1 (en)1997-07-251999-02-04Minnesota Innovative Technologies & Instruments Corporation (Miti)Control device for supplying supplemental respiratory oxygen
US6532958B1 (en)1997-07-252003-03-18Minnesota Innovative Technologies & Instruments CorporationAutomated control and conservation of supplemental respiratory oxygen
US20030145852A1 (en)1997-07-252003-08-07Minnesota Innovative Technologies And InstrumentsControl of supplemental respiratory Oxygen
US6561187B2 (en)1997-07-252003-05-13Minnesota Innovative Technologies & Instruments CorporationControl of supplemental respiratory oxygen
US6655382B1 (en)1997-09-182003-12-02The United States Of America As Represented By The Secretary Of Health And Human ServicesSpontaneous breathing apparatus and method
US5937854A (en)1998-01-061999-08-17Sensormedics CorporationVentilator pressure optimization method and apparatus
US6578575B1 (en)1998-04-032003-06-17Siemens Elema AbMethod and apparatus for optimization of mechanical ventilation
WO1999061088A1 (en)1998-05-221999-12-02Resmed LimitedVentilatory assistance for treatment of cardiac failure and cheyne-stokes breathing
US6371114B1 (en)1998-07-242002-04-16Minnesota Innovative Technologies & Instruments CorporationControl device for supplying supplemental respiratory oxygen
US20020110849A1 (en)1999-01-282002-08-15Steffen LeonhardtNon-invasive method for optimizing the respiration of atelectatic lungs
US6390091B1 (en)1999-02-032002-05-21University Of FloridaMethod and apparatus for controlling a medical ventilator
US6796305B1 (en)1999-06-302004-09-28University Of Florida Research Foundation, Inc.Ventilator monitor system and method of using same
US7210478B2 (en)1999-06-302007-05-01University Of Florida Research Foundation, Inc.Ventilator monitor system and method of using same
US20070000494A1 (en)1999-06-302007-01-04Banner Michael JVentilator monitor system and method of using same
US20040003813A1 (en)*1999-06-302004-01-08Banner Michael J.Medical ventilator and method of controlling same
US6663574B2 (en)2000-05-222003-12-16Comedica Technologies IncorporatedLung inflection point monitor apparatus connection device
US6355002B1 (en)2000-05-222002-03-12Comedica Technologies IncorporatedLung inflection point monitor apparatus and method
US6752151B2 (en)2000-09-252004-06-22Respironics, Inc.Method and apparatus for providing variable positive airway pressure
US6671529B2 (en)2000-12-122003-12-30University Of MiamiSystem and method for closed loop controlled inspired oxygen concentration
US6512938B2 (en)2000-12-122003-01-28Nelson R. ClaureSystem and method for closed loop controlled inspired oxygen concentration
US20030111078A1 (en)2001-06-212003-06-19Habashi Nader MaherVentilation method and control of a ventilator based on same
US20030060725A1 (en)2001-09-272003-03-27Kline Jeffrey A.Non-invasive device and method for the diagnosis of pulmonary vascular occlusions
US20050051168A1 (en)*2003-08-042005-03-10Devries Douglas F.Portable ventilator system
US7802571B2 (en)2003-11-212010-09-28Tehrani Fleur TMethod and apparatus for controlling a ventilator

Non-Patent Citations (56)

* Cited by examiner, † Cited by third party
Title
A. B. Otis, W. O. Fenn, and H. Rahn, "Mechanics of breathing in man," Journal of Applied Physiology, vol. 2, pp. 592-607, 1950.
A. H. Morris, C. J. Wallace, T. P. Clemmer, J. F. Orme Jr., L. K. Weaver, N. C. Dean, S. Butler, M. R. Suchyta, T. D. East, D. F. Sittig, "Extracorporeal CO2 removal therapy for adult respiratory distress syndrome patients: a computerized protocol controlled trial," Râeanimation, soins intensifs, maedecine d'urgence, vol. 6(7), pp. 485-490, 1990.
A. M. Hewlett, A. S. Platt, V. G. Terry, "Mandatory minute volume," Anaesthesia, vol. 32, pp. 163-169, 1977.
A.Rossi et al., Intrinsic positive end-expiratory pressure (PEEPi), 21 Intensive Care Med., 522-536 (1995) ("Rossi").
A. Sano, and M. Kikucki, "Adaptive control of arterial oxygen pressure of newborn infants under incubator oxygen treatments," Proceedings of IEE, vol. 132(Pt. D., No. 5), pp. 205-211, 1985.
C. Yu, W. G. He, J. M. So, R. Roy, H. Kaufman, and J. C. Newell, "Improvement in arterial oxygen control using multiple model adaptive control procedures," IEEE Transactions on Biomedical Engineering, BME-34(8), pp. 567-574, 1987.
D. B. Raemer, X. Ji, and G. P. Topulos, "FIX controller: an instrument to automatically adjust inspired oxygen fraction using feedback control from a pulse oximeter," Journal of Clinical Monitoring, vol. 13, pp. 91-101, 1997.
D. F. Sittig, R. M. Gardner, A. H. Morris, and C. J. Wallace, "Clinical evaluation of computer-based respiratory care algorithms," International Journal of Clinical Monitoring and Computing, vol. 7, pp. 177-185, 1990.
D.B. Waisel et al., PEFIOS: a PEEP-FIO2-SPO2 Closed Loop Controller of Arterial Oxygen Saturation, 79(3A) Anaesthesiology A287 (1993).
D.B. Waisel et al., PEFIOS: An Expert Closed Loop Oxygenation Algorithm, MEDINFO 95 PROC. 1132-1136 (1995).
F. T. Tehrani, "A control system for oxygen therapy of premature infants," in The Proceedings of the 23rd Annual International Conference of IEEE Engineering in Medicine and Biology Society, vol. 23(2), pp. 2059-2062, Oct. 2001.
F. T. Tehrani, "A microcomputer oxygen control system for ventilatory therapy," Annals of Biomedical Engineering, vol. 20(5), pp. 547-558, 1992.
F. T. Tehrani, "Mathematical analysis and computer simulation of the respiratory system in the newborn infant," IEEE Transactions on Biomedical Engineering, vol. 40, No. 5, pp. 475-481, 1993.
F. T. Tehrani, and A. R. Bazar, "A feedback controller for supplemental oxygen treatment of newborn infants: a simulation study," Medical Engineering and Physics, vol. 16, pp. 329-333, 1994.
F. T. Tehrani, M. Rogers, T. Lo, T. Malinowski, S. Afuwape, M. Lum, B. Grundl, and M. Terry, "Closed-loop control of the inspired fraction of oxygen in mechanical ventilation," Journal of Clinical Monitoring and Computing, vol. 17(6), pp. 367-376, 2002.
F. W. Chapman, J. C. Newell, and R. J. Roy, "A feedback controller for ventilatory therapy," Annals of Biomedical Engineering, vol. 13, pp. 359-372, 1985.
Final Written Decision, IPR2020-01199, U.S. Pat. No. 7,802,571 B2, Hamilton Technologies LLC v. Fleur Tehrani, Dec. 28, 2021 (FWD).
G. A. Lotti, J. X. Brunner, A. Braschi, T. Laubscher, M. C. Olivei, A. Palo, C. Galbusera, A. Comelli, "Closed-loop control of airway occlusion pressure at 0.1 second (P0.1) applied to pressure-support ventilation: Algorithm and application in intubated patients," Critical Care Medicine, vol. 24(5), pp. 771-779, 1996.
G. A. Saxton, Jr., and G. H. Myers, "A servomechanism for automatic regulation of pulmonary ventilation," Journal of Applied Physiology, vol. 11, pp. 326-328, 1957.
I. R. Beddis, P. Collins, N. M. Levy, S. Godfrey, and M. Silverman, "New technique for servo-control of arterial oxygen tension in preterm infants," Archives of Disease in Childhood, vol. 54, pp. 278-280, 1979.
J.Anderson and T. East, A Closed-Loop Controller for Mechanical Ventilation of Patients with ARDS, 38 Biomed Sci. Instrum. 289-294 (2002) ("Anderson").
J. Anderson et al., Clinical Trial of a Non-Linear Closed-Loop Controller for Oxygenation During ARDS, 22(A 188) Critical Care Medicine, Jan. 1994 (Anderson 2).
J. R. Anderson, T. D. East, J. Coombs, T. Clemmer, J. Orme, L. Weaver, "Clinical trial of a non-linear closed-loop controller for oxygenation during ARDS," Critical Care Medicine, vol. 22, A188, Jan. 1994.
J. R. Coles, W. A. Brown, and D. G. Lampard, "Computer control of ventilation and anesthesia," Medical and Biological Engineering, vol. 11, pp. 262-267, 1973.
J. Schaublin, M. Derighetti, P. Feigenwinter, S. Petersen-Felix, and A. M. Zbinden, "Fuzzy logic control of mechanical ventilation during anesthesia," British Journal of Anesthesiology, vol. 77, pp. 636-641, 1996.
J.M. Halter et al, "Positive End-Expiratory Pressure after a Recruitment Maneuver Prevents Both Alveolar Collapse and Recruitment/Decrectuitment," 2003, American Journal of Respiratory and Critical Care Medicine, 167:1620-1626.
K. B. Ohlson, D. R. Westenskow, and W. S. Jordan, "A microprocessor based feedback controller for mechanical ventilation," Annals of Biomedical Engineering, vol. 10, pp. 35-48, 1982.
L.Carmichael et al., Diagnosis and Therapy of Acute Respiratory Distress Syndrome in Adults: An International Survey, 11(1) Journal of Critical Care 9-18 (1996) ("Carmichael").
M. Dojat, F. Pachet, Z. Guessoum, D. Touchard, A. Harf, L. Brochard, "NeoGanesh: a working system for the automated control of assisted ventilation in ICUs," Artificial Intelligence in Medicine, vol. 11, pp. 97-117, 1997.
M. Dojat, L. Brochard, F. Lemaire, and A. Harf, "A knowledge-based system for assisted ventilation of patients in intensive care units," International Journal of Clinical Monitoring and Computing, vol. 9, pp. 239-250, 1992.
M. H. Giard, F. O. Bertrand, D. Robert, and J. Pernier, "An algorithm for automatic control of O2 and CO2 in artificial ventilation," IEEE Transactions on Biomedical Engineering, vol. BME-32, No. 9, pp. 658-667, 1985.
M. J. Frumin, N. A. Bergman, and D. A. Holaday, "Carbon dioxide and oxygen blood levels with a carbon dioxide controlled artificial respirator," Anesthesiology, vol. 20(3), pp. 313-321, 1959.
N. R. Macintyre, Building Consensus on the Use of MechanicalVentilation, 104 (2) Chest 334-335 (1993).
P. E. Morozoff, and R. W. Evans, "Closed loop control of SaO2 in the neonate," Biomedical Instrumentation and Technology, vol. 26, pp. 117-123, 1992.
P. Saura, L. Blanch, "How to set positive end-expiratory pressure,"0 Respiratory Care, vol. 47 (3), pp. 279-295, 2002.
R. E. Dugdale, R. G. Cameron, and G. T. Lealman, "Closed-loop control of the partial pressure of arterial oxygen in neonates," Clinical Physics and Physiological Measurement, vol. 9(4), pp. 291-305, 1988.
R. G. Ritchie, E. A. Ernst, B. L. Pate, J. P. Pearson, and L. C. Sheppard, "Automatic control of anesthetic delivery and ventilation during surgery," Medical Progress through Technology, vol. 16, pp. 61-67, 1990.
R. G. Ritchie, E. A. Ernst, B. L. Pate, J. P. Pearson, and L. C. Sheppard, "Closed-loop control of an anesthesia delivery system: Development and animal testing," IEEE Transactions on Biomedical Engineering, BME-34(6), pp. 437-443, 1987.
R. L. Coon, E. J. Zuperku, and J. P. Kampine, "Systemic arterial blood pH servo control of mechanical ventilation," Anesthesiology, vol. 49(3), pp. 201-204, 1978.
R. Rudowski, A. Bokliden, A. Carstensen, H. Gill, U. Ludwigs, G. Matell, "Multivariable optimization of mechanical ventilation. A linear programming approach." International Journal of Clinical Monitoring and Computing. vol. 8, pp. 107-115, 1991.
R. Rudowski, L. Skreta, S. Baehrendtz, A. Bokliden, and G. Matell, "Lung function analysis and optimization during artificial ventilation. A personal computer-based system." Computer Methods and Programs in Biomedicine, vol. 31, pp. 33-42, 1990.
R.G. Brower et al., "Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure," 2003, Critical Care Medicine, 31(11):2592-2597.
S.E. Lapinsky et al., "Safety and efficacy of a sustained inflation for alveolar recruitment in adults with respiratory failure," 1999, Intensive Care Medicine, 25:1297-1301.
T. D. East, C. R. Tolle, S. McJames, R. M. Farrell, J. X. Brunner, "A non-linear closed-loop controller for oxygenation based on a clinically proven fifth dimensional quality surface," Anesthesiology, vol. 75, A468, 1991.
T. D. East, J. C. C. M. Veen, T. A. Jonker, N. L. Pace, and S. McJames, "Computer-controlled positive end-expiratory pressure titration for effective oxygenation without frequent blood gases." Critical Care Medicine, vol. 16(3), pp. 252-257, 1988.
T. D. East, K. P. Adriano, N. L. Pace, "Computer-controlled optimization of positive end-expiratory pressure," Critical Care Medicine, vol. 14, No. 9, pp. 792-797, 1986.
T. Fernando, J. Cade, and J. Packer, "Automatic control of arterial carbon dioxide tension in mechanically ventilated patients," IEEE Transactions on Information Technology in Biomedicine, vol. 6(4), pp. 269-276, 2002.
T. L. Fernando, J. S. Packer, and J. F. Cade, "A closed-loop system for controlling blood oxygen and carbon dioxide levels in mechanically ventilated patients," Control Eng. Practice, vol. 3, No. 10, pp. 1433-1440, 1995.
T. Lo, F. T. Tehrani, M. Rogers, M. Lum, T. Malinowski, S. Afuwape, M. Terry, B. Grundl, "A dual closed-loop controller for mechanical ventilation," (abstract), American Journal of Respiratory and Critical Care Medicine, vol. 165(8), supplement, part 2, Apr. 2002.
T. P. Laubscher, W. Heinrichs, N. Weiler, G. Hartmann, and J. X. Brunner, "An adaptive lung ventilation controller," IEEE Transactions on Biomedical Engineering, vol. 41(1), pp. 51-59, 1994.
The Acute Respiratory Distress Syndrome Network, Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome, 342(18) The New England Journal of Medicine 1301-1308 (May 4, 2000) ("Ardsnet").
United States Court of Appeals for the Federal Circuit, Fleur Tehrani v. Hamilton Technologies LLC, Case# 2022-1732, Non-Precedential Opinion, Jun. 28, 2023 (the Opinion).
United States Supreme Court, Order List Regarding Petitions for Writ of Certiorari, Feb. 20, 2024, Petition Denied, Case 23-575, p. 5, Fleur Tehrani, Appellant v. Hamilton Technologies LLC, Appellee.
W. F. Fincham, and F. T. Tehrani, "A mathematical model of the human respiratory system," Journal of Biomedical Engineering, vol. 5, pp. 125-133, 1983.
Y. Mitamura, T. Mikami, H. Sugawara, and C. Yoshimoto, "An optimally controlled respirator," IEEE Transactions on Biomedical Engineering, BME-18, pp. 330-337, 1971.
Y. Mitamura, T. Mikami, K. Yamamoto, and K. Mimura, "A dual control system for assisting respiration," Medical and Biological Engineering, vol. 13(6), pp. 846-854, 1975.

Also Published As

Publication numberPublication date
WO2005051280A2 (en)2005-06-09
WO2005051280A3 (en)2006-05-26
GB2423721B (en)2008-11-12
GB2423721A (en)2006-09-06
GB0611065D0 (en)2006-07-12
AU2004292955A1 (en)2005-06-09
AU2004292955B2 (en)2010-02-18
US20050109340A1 (en)2005-05-26
US7802571B2 (en)2010-09-28
NZ546941A (en)2009-01-31
CA2545570A1 (en)2005-06-09
CA2545570C (en)2012-01-03

Similar Documents

PublicationPublication DateTitle
USRE50219E1 (en)Method and apparatus for controlling a ventilator
US9604021B2 (en)Automatic control system for mechanical ventilation for active or passive subjects
JP5016595B2 (en) Apparatus and method for controlling inspiratory oxygen concentration
AU757163B2 (en)Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
US20080202522A1 (en)Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230062A1 (en)Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes
US20080202517A1 (en)Setting madatory mechanical ventilation parameters based on patient physiology
US20080202518A1 (en)Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230061A1 (en)Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US20080230064A1 (en)Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080230060A1 (en)Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
EP1961378A1 (en)Setting mandatory mechanical ventilation parameters based on patient physiology
US20230157574A1 (en)End tidal carbon dioxide measurement during high flow oxygen therapy
Tehrani et al.Closed-loop control of artificial respiration
US20080202519A1 (en)Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230063A1 (en)Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time

Legal Events

DateCodeTitleDescription
FEPPFee payment procedure

Free format text:ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPPFee payment procedure

Free format text:ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY


[8]ページ先頭

©2009-2025 Movatter.jp